BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Koppe MJ, Boerman OC, Oyen WJ, Bleichrodt RP. Peritoneal carcinomatosis of colorectal origin: Incidence and current treatment strategies. Ann Surg. 2006;243:212-222. [PMID: 16432354 DOI: 10.1097/01.sla.0000197702.46394.16] [Cited by in Crossref: 346] [Cited by in F6Publishing: 306] [Article Influence: 21.6] [Reference Citation Analysis]
Number Citing Articles
1 Karlsson S, Nyström H. The extracellular matrix in colorectal cancer and its metastatic settling – alterations and biological implications. Critical Reviews in Oncology/Hematology 2022. [DOI: 10.1016/j.critrevonc.2022.103712] [Reference Citation Analysis]
2 Evers DJ, Verwaal VJ. Indication for oophorectomy during cytoreduction for intraperitoneal metastatic spread of colorectal or appendiceal origin. Br J Surg. 2011;98:287-292. [PMID: 21046680 DOI: 10.1002/bjs.7303] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
3 Dakwar GR, Zagato E, Delanghe J, Hobel S, Aigner A, Denys H, Braeckmans K, Ceelen W, De Smedt SC, Remaut K. Colloidal stability of nano-sized particles in the peritoneal fluid: Towards optimizing drug delivery systems for intraperitoneal therapy. Acta Biomaterialia 2014;10:2965-75. [DOI: 10.1016/j.actbio.2014.03.012] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 5.9] [Reference Citation Analysis]
4 Matsuzaki H, Kamiya M, Iwatate RJ, Asanuma D, Watanabe T, Urano Y. Novel Hexosaminidase-Targeting Fluorescence Probe for Visualizing Human Colorectal Cancer. Bioconjug Chem 2016;27:973-81. [PMID: 27009615 DOI: 10.1021/acs.bioconjchem.6b00037] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 5.3] [Reference Citation Analysis]
5 Klaver YL, Lemmens VE, de Hingh IH. Outcome of surgery for colorectal cancer in the presence of peritoneal carcinomatosis. Eur J Surg Oncol 2013;39:734-41. [PMID: 23523316 DOI: 10.1016/j.ejso.2013.03.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
6 Hompes D, D'Hoore A, Van Cutsem E, Fieuws S, Ceelen W, Peeters M, Van der Speeten K, Bertrand C, Legendre H, Kerger J. The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: A Belgian multicentre prospective phase II clinical study. Ann Surg Oncol. 2012;19:2186-2194. [PMID: 22395983 DOI: 10.1245/s10434-012-2264-z] [Cited by in Crossref: 75] [Cited by in F6Publishing: 69] [Article Influence: 7.5] [Reference Citation Analysis]
7 Bartlett EK, Choudhury RA, Roses RE, Fraker DL, Kelz RR, Karakousis GC. Intraperitoneal chemotherapy at the time of surgery is not associated with increased 30-day morbidity and mortality following colorectal resection. Ann Surg Oncol 2015;22:1664-72. [PMID: 25124471 DOI: 10.1245/s10434-014-3975-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
8 Ito K, Takemura N, Inagaki F, Mihara F, Kurokawa T, Gohda Y, Kiyomatsu T, Yano H, Kokudo N. Hepatectomy for metachronous colorectal liver metastases following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases: a report of three cases. World J Surg Oncol 2019;17:99. [PMID: 31196097 DOI: 10.1186/s12957-019-1646-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Sammartino P, Sibio S, Biacchi D, Cardi M, Accarpio F, Mingazzini P, Rosati MS, Cornali T, Di Giorgio A. Prevention of Peritoneal Metastases from Colon Cancer in High-Risk Patients: Preliminary Results of Surgery plus Prophylactic HIPEC. Gastroenterol Res Pract. 2012;2012:141585. [PMID: 22645605 DOI: 10.1155/2012/141585] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 4.1] [Reference Citation Analysis]
10 Virzì S, Iusco D, Baratti D, Bonomi S, Grassi A, Kusamura S, Deraco M. Pilot study of adjuvant hyperthermic intraperitoneal chemotherapy in patients with colorectal cancer at high risk for the development of peritoneal metastases. Tumori 2013;99:589-95. [DOI: 10.1177/030089161309900505] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
11 Boldrini L, Romano A, Placidi L, Mattiucci GC, Chiloiro G, Cusumano D, Pollutri V, Antonelli MV, Indovina L, Gambacorta MA, Valentini V. Case Report: First in Human Online Adaptive MR Guided SBRT of Peritoneal Carcinomatosis Nodules: A New Therapeutic Approach for the Oligo-Metastatic Patient. Front Oncol 2020;10:601739. [PMID: 33384958 DOI: 10.3389/fonc.2020.601739] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Paulo J, Oliveira J, Silva M, Silva P, Leite F, Valente R, Sousa A, Lobo M. Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy: Analysis of Perioperative Risk Factors and Impact on Outcome. Cureus. [DOI: 10.7759/cureus.22937] [Reference Citation Analysis]
13 Ravn S, Heide-Jørgensen U, Christiansen CF, Verwaal VJ, Hagemann-Madsen RH, Iversen LH. Overall risk and risk factors for metachronous peritoneal metastasis after colorectal cancer surgery: a nationwide cohort study. BJS Open 2020;4:284-92. [PMID: 32207578 DOI: 10.1002/bjs5.50247] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
14 Francescutti V, Rivera L, Seshadri M, Kim M, Haslinger M, Camoriano M, Attwood K, Kane JM 3rd, Skitzki JJ. The benefit of intraperitoneal chemotherapy for the treatment of colorectal carcinomatosis. Oncol Rep 2013;30:35-42. [PMID: 23673557 DOI: 10.3892/or.2013.2473] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
15 Zou Y, Chen X, Zhang X, Shen Z, Cai J, Tan Y, Weng J, Rong Y, Lin X. Clinical outcomes of curative treatment for colorectal liver metastases combined with cytoreductive surgery and intraperitoneal chemotherapy for peritoneal metastases: a systematic review and meta-analysis of current evidence. Int J Hyperthermia 2020;37:944-54. [PMID: 32787474 DOI: 10.1080/02656736.2020.1803424] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Aranda E, Abad A, Carrato A, Cervantes A, García-Foncillas J, García Alfonso P, García Carbonero R, Gómez España A, Tabernero JM, Díaz-Rubio E. Treatment recommendations for metastatic colorectal cancer. Clin Transl Oncol 2011;13:162-78. [PMID: 21421461 DOI: 10.1007/s12094-011-0636-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
17 Beal EW, Chen JC, Kim A, Johnston FM, Abbott DE, Raoof M, Grotz TE, Fournier K, Dineen S, Veerapong J, Clarke C, Staley C, Patel SH, Lambert L, Cloyd JM. Is CRS-HIPEC Still Indicated in Patients With Extraperitoneal Disease? J Surg Res 2022;277:269-78. [PMID: 35525209 DOI: 10.1016/j.jss.2022.04.007] [Reference Citation Analysis]
18 Bhullar DS, Barriuso J, Mullamitha S, Saunders MP, O'Dwyer ST, Aziz O. Biomarker concordance between primary colorectal cancer and its metastases. EBioMedicine 2019;40:363-74. [PMID: 30733075 DOI: 10.1016/j.ebiom.2019.01.050] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 8.7] [Reference Citation Analysis]
19 Hentzen JEKR, de Jongh SJ, Hemmer PHJ, van der Plas WY, van Dam GM, Kruijff S. Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: A narrative review. J Surg Oncol. 2018;118:332-343. [PMID: 29938400 DOI: 10.1002/jso.25106] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
20 Van't Erve I, Rovers KP, Constantinides A, Bolhuis K, Wassenaar EC, Lurvink RJ, Huysentruyt CJ, Snaebjornsson P, Boerma D, van den Broek D, Buffart TE, Lahaye MJ, Aalbers AG, Kok NF, Meijer GA, Punt CJ, Kranenburg O, de Hingh IH, Fijneman RJ. Detection of tumor-derived cell-free DNA from colorectal cancer peritoneal metastases in plasma and peritoneal fluid. J Pathol Clin Res 2021;7:203-8. [PMID: 33635598 DOI: 10.1002/cjp2.207] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
21 Sugarbaker PH, Sammartino P, Tentes A. Eradication of minimal residual disease in the perioperative period in primary colon cancer. Colorectal Cancer 2015;4:157-66. [DOI: 10.2217/crc.15.20] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
22 Xiang W, Shi R, Zhang D, Kang X, Zhang L, Yuan J, Zhang X, Miao H. Dietary fats suppress the peritoneal seeding of colorectal cancer cells through the TLR4/Cxcl10 axis in adipose tissue macrophages. Signal Transduct Target Ther 2020;5:239. [PMID: 33060562 DOI: 10.1038/s41392-020-00327-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
23 Baratti D, Kusamura S, Iusco D, Bonomi S, Grassi A, Virzì S, Leo E, Deraco M. Postoperative Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Affect Long-term Outcome of Patients With Peritoneal Metastases From Colorectal Cancer: a Two-Center Study of 101 Patients. Diseases of the Colon & Rectum 2014;57:858-68. [DOI: 10.1097/dcr.0000000000000149] [Cited by in Crossref: 72] [Cited by in F6Publishing: 32] [Article Influence: 9.0] [Reference Citation Analysis]
24 Sloothaak DA, Mirck B, Punt CJ, Bemelman WA, van der Bilt JD, D'Hoore A, Tanis PJ. Intraperitoneal chemotherapy as adjuvant treatment to prevent peritoneal carcinomatosis of colorectal cancer origin: A systematic review. Br J Cancer. 2014;111:1112-1121. [PMID: 25025964 DOI: 10.1038/bjc.2014.369] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
25 Sánchez-Hidalgo JM, Rodríguez-Ortiz L, Arjona-Sánchez Á, Rufián-Peña S, Casado-Adam Á, Cosano-Álvarez A, Briceño-Delgado J. Colorectal peritoneal metastases: Optimal management review. World J Gastroenterol 2019; 25(27): 3484-3502 [PMID: 31367152 DOI: 10.3748/wjg.v25.i27.3484] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 24] [Article Influence: 9.3] [Reference Citation Analysis]
26 Roviello F, Marrelli D, Neri A, Cerretani D, de Manzoni G, Pedrazzani C, Cioppa T, Nastri G, Giorgi G, Pinto E. Treatment of peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion (IHCP): postoperative outcome and risk factors for morbidity. World J Surg. 2006;30:2033-2040; discussion 2041-2042. [PMID: 17006608 DOI: 10.1007/s00268-006-0498-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
27 Iwata Y, Kinoshita T, Kimura K, Komori K, Hayashi D, Akazawa T, Shigeyoshi I, Tsutsuyama M, Kawakami J, Ouchi A, Natsume S, Uemura N, Ito Y, Misawa K, Senda Y, Abe T, Ito S, Tajika M, Yatabe Y, Yoshida K, Shimizu Y. A long-term survival case of Sister Mary Joseph's nodule caused by colon cancer and treated with a multidisciplinary approach. Nagoya J Med Sci 2019;81:325-9. [PMID: 31239600 DOI: 10.18999/nagjms.81.2.325] [Reference Citation Analysis]
28 Liesenfeld LF, Hillebrecht HC, Klose J, Schmidt T, Schneider M. Impact of Perfusate Concentration on Hyperthermic Intraperitoneal Chemotherapy Efficacy and Toxicity in a Rodent Model. J Surg Res 2020;253:262-71. [PMID: 32388389 DOI: 10.1016/j.jss.2020.03.067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
29 Moral ÁSD, Viejo EP, Romero IM, Pérez FP. Results of systematic second-look surgery plus hipec in perforated or pt4 colon cancer. Case series. Ann Med Surg (Lond) 2021;62:386-90. [PMID: 33552500 DOI: 10.1016/j.amsu.2021.01.072] [Reference Citation Analysis]
30 Sommariva A, Ansaloni L, Baiocchi GL, Cascinu S, Cirocchi R, Coccolini F, Deraco M, Fiorentini G, Gelmini R, Di Giorgio A, Lippolis PV, Pasqual EM, Sassaroli C, Macrì A, Sammartino P, Scaringi S, Valle M, Vaira M. Diagnostic and therapeutic algorithm for colorectal peritoneal metastases. A consensus of the peritoneal surface malignancies onco-team of the Italian society of surgical oncology. Eur J Surg Oncol 2021;47:164-71. [PMID: 33028502 DOI: 10.1016/j.ejso.2020.09.035] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Loktionov A. Cell exfoliation in the human colon: myth, reality and implications for colorectal cancer screening. Int J Cancer. 2007;120:2281-2289. [PMID: 17351899 DOI: 10.1002/ijc.22647] [Cited by in Crossref: 61] [Cited by in F6Publishing: 55] [Article Influence: 4.1] [Reference Citation Analysis]
32 Badia S, Picchia S, Bellini D, Ferrari R, Caruso D, Paolantonio P, Carbone I, Laghi A, Rengo M. The Role of Contrast-Enhanced Imaging for Colorectal Cancer Management. Curr Colorectal Cancer Rep 2019;15:181-9. [DOI: 10.1007/s11888-019-00443-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
33 Weber T, Roitman M, Link KH. [Peritoneal carcinomatosis of colorectal origin: results of cytoreductive surgery with peritonectomy and hyperthermic intraoperative chemotherapy]. Chirurg 2013;84:130, 132-9. [PMID: 23247560 DOI: 10.1007/s00104-012-2419-2] [Reference Citation Analysis]
34 Posaric-Bauden M, Isaksson K, Akerberg D, Andersson R, Tingstedt B. Novel anti-adhesive barrier Biobarrier reduces growth of colon cancer cells. J Surg Res 2014;191:196-202. [PMID: 24801543 DOI: 10.1016/j.jss.2014.04.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
35 Davis CH, Alexander HR Jr. What is the Current Role of Hyperthermic Intraperitoneal Chemotherapy in Colorectal Cancer? Adv Surg 2021;55:159-74. [PMID: 34389090 DOI: 10.1016/j.yasu.2021.05.012] [Reference Citation Analysis]
36 De Smet L, Ceelen W, Remon JP, Vervaet C. Optimization of drug delivery systems for intraperitoneal therapy to extend the residence time of the chemotherapeutic agent. ScientificWorldJournal 2013;2013:720858. [PMID: 23589707 DOI: 10.1155/2013/720858] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 3.7] [Reference Citation Analysis]
37 McConnell YJ, Mack LA, Francis WP, Ho T, Temple WJ. HIPEC + EPIC versus HIPEC-alone: differences in major complications following cytoreduction surgery for peritoneal malignancy. J Surg Oncol 2013;107:591-6. [PMID: 23129533 DOI: 10.1002/jso.23276] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
38 Macrì A, Arcoraci V, Belgrano V, Caldana M, Carbonari L, Cioppa T, De Cian F, De Manzoni G, De Simone M, Giardina C, Muffatti F, Orsenigo E, Robella M, Roviello F, Saladino E, Sammartino P, Vaira M. Short-term outcome of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy used as treatment of colo-rectal carcinomatosis: a multicentric study. Updates Surg 2020;72:163-70. [PMID: 31729630 DOI: 10.1007/s13304-019-00691-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
39 Duzgun O, Kalin M. Safety of coloanal/ileoanal anastomosis during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: results of 20 consecutive patients. J Int Med Res 2019;47:4911-9. [PMID: 31502496 DOI: 10.1177/0300060519872618] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
40 Kondo Y, Murayama Y, Konishi H, Morimura R, Komatsu S, Shiozaki A, Kuriu Y, Ikoma H, Kubota T, Nakanishi M. Fluorescent detection of peritoneal metastasis in human colorectal cancer using 5-aminolevulinic acid. Int J Oncol. 2014;45:41-46. [PMID: 24821500 DOI: 10.3892/ijo.2014.2417] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 5.4] [Reference Citation Analysis]
41 Rivard JD, McConnell YJ, Temple WJ, Mack LA. Cytoreduction and heated intraperitoneal chemotherapy for colorectal cancer: are we excluding patients who may benefit? J Surg Oncol. 2014;109:104-109. [PMID: 24449172 DOI: 10.1002/jso.23446] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
42 Willaert W, Van Der Speeten K, Liberale G, Ceelen W. BEV-IP: Perioperative chemotherapy with bevacizumab in patients undergoing cytoreduction and intraperitoneal chemoperfusion for colorectal carcinomatosis. BMC Cancer. 2015;15:980. [PMID: 26673788 DOI: 10.1186/s12885-015-1954-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
43 Serratì S, Porcelli L, Fragassi F, Garofoli M, Di Fonte R, Fucci L, Iacobazzi RM, Palazzo A, Margheri F, Cristiani G, Albano A, De Luca R, Altomare DF, Simone M, Azzariti A. The Interaction between Reactive Peritoneal Mesothelial Cells and Tumor Cells via Extracellular Vesicles Facilitates Colorectal Cancer Dissemination. Cancers (Basel) 2021;13:2505. [PMID: 34065529 DOI: 10.3390/cancers13102505] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 Radwan AA, Alanazi FK. Targeting cancer using cholesterol conjugates. Saudi Pharm J 2014;22:3-16. [PMID: 24493968 DOI: 10.1016/j.jsps.2013.01.003] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 4.2] [Reference Citation Analysis]
45 van Santvoort HC, Braam HJ, Spekreijse KR, Koning NR, de Bruin PC, de Vries Reilingh TS, Boerma D, Smits AB, Wiezer MJ, van Ramshorst B. Peritoneal carcinomatosis in t4 colorectal cancer: Occurrence and risk factors. Ann Surg Oncol. 2014;21:1686-1691. [PMID: 24398543 DOI: 10.1245/s10434-013-3461-0] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
46 Pelz JO, Chua TC, Esquivel J, Stojadinovic A, Doerfer J, Morris DL, Maeder U, Germer CT, Kerscher AG. Evaluation of best supportive care and systemic chemotherapy as treatment stratified according to the retrospective peritoneal surface disease severity score (PSDSS) for peritoneal carcinomatosis of colorectal origin. BMC Cancer. 2010;10:689. [PMID: 21176206 DOI: 10.1186/1471-2407-10-689] [Cited by in Crossref: 78] [Cited by in F6Publishing: 62] [Article Influence: 6.5] [Reference Citation Analysis]
47 Tang Q, Wang Y, Huang R, You Q, Wang G, Chen Y, Jiang Z, Liu Z, Yu L, Muhammad S, Wang X. Preparation of anti-tumor nanoparticle and its inhibition to peritoneal dissemination of colon cancer. PLoS One 2014;9:e98455. [PMID: 24896096 DOI: 10.1371/journal.pone.0098455] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
48 Li C, Chang T, Chen Y, Tsai H, Huang C, Su W, Ma C, Yin T, Chen P, Wang J. Clinical Outcomes of Patients with Peritoneal Metastasis-Only Colorectal Cancer Treated with First-Line Bevacizumab and FOLFIRI Through Irinotecan Dose Escalation According to UGT1A1 Polymorphism: Compared to Liver Metastasis-Only, and Lung Metastasis-Only. CMAR 2022;Volume 14:1541-9. [DOI: 10.2147/cmar.s355318] [Reference Citation Analysis]
49 Lee RM, Cardona K, Russell MC. Historical perspective: Two decades of progress in treating metastatic colorectal cancer. J Surg Oncol 2019;119:549-63. [PMID: 30806493 DOI: 10.1002/jso.25431] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
50 de Jong LAW, Elekonawo FMK, Lambert M, de Gooyer JM, Verheul HMW, Burger DM, de Wilt JHW, Chatelut E, Ter Heine R, de Reuver PR, Bremers AJA, van Erp NP. Wide variation in tissue, systemic, and drain fluid exposure after oxaliplatin-based HIPEC: results of the GUTOX study. Cancer Chemother Pharmacol 2020;86:141-50. [PMID: 32594200 DOI: 10.1007/s00280-020-04107-y] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
51 Kanzaki A, Kasuya H, Yamamura K, Sahin TT, Nomura N, Shikano T, Shirota T, Tan G, Fukuda S, Misawa M, Nishikawa Y, Yamada S, Fujii T, Sugimoto H, Nomoto S, Takeda S, Kodera Y, Nakao A. Antitumor efficacy of oncolytic herpes simplex virus adsorbed onto antigen-specific lymphocytes. Cancer Gene Ther 2012;19:292-8. [DOI: 10.1038/cgt.2011.91] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
52 Mikuła-Pietrasik J, Stryczyński Ł, Uruski P, Tykarski A, Książek K. Procancerogenic activity of senescent cells: A case of the peritoneal mesothelium. Ageing Res Rev 2018;43:1-9. [PMID: 29355719 DOI: 10.1016/j.arr.2018.01.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
53 Choi AH, Senthil M. ASO Author Reflections: Real-World Incidence of Peritoneal Carcinomatosis After Colon Cancer Resection and Why It Matters. Ann Surg Oncol 2020;27:4949. [PMID: 32627117 DOI: 10.1245/s10434-020-08773-3] [Reference Citation Analysis]
54 Oosterling SJ, van der Bij GJ, Bögels M, ten Raa S, Post JA, Meijer GA, Beelen RH, van Egmond M. Anti-beta1 integrin antibody reduces surgery-induced adhesion of colon carcinoma cells to traumatized peritoneal surfaces. Ann Surg 2008;247:85-94. [PMID: 18156927 DOI: 10.1097/SLA.0b013e3181588583] [Cited by in Crossref: 36] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
55 Bruin SC, Verwaal VJ, Vincent A, van't Veer LJ, van Velthuysen ML. A clinicopathologic analysis of peritoneal metastases of colorectal and appendiceal origin. Ann Surg Oncol. 2010;17:2330-2340. [PMID: 20232161 DOI: 10.1245/s10434-010-0984-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
56 Laks S, Adileh M, Ben-Yaacov A, Nissan A. ASO Author Reflections: If Once Is Good, Is Twice Just as Good? A critical evaluation of Repeat CRS-HIPEC for Colorectal Peritoneal Metastases. Ann Surg Oncol 2021;28:5339-40. [PMID: 33604829 DOI: 10.1245/s10434-021-09704-6] [Reference Citation Analysis]
57 Botchkina IL, Rivadeneira DE, Watkins K, Karpeh MS, Botchkina GI. Clinical significance of telomerase activity in peritoneal disseminated cells: gastrointestinal cancers. Mol Med 2008;14:45-54. [PMID: 17973027 DOI: 10.2119/2007-00069.Botchkina] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
58 Jaeck D, Oussoultzoglou E, Rosso E. Hepatectomy for colorectal metastases in the presence of extrahepatic disease. Surg Oncol Clin N Am 2007;16:507-23, viii. [PMID: 17606191 DOI: 10.1016/j.soc.2007.04.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
59 Lai ECH, Tang C, Ha JPY, Tsui DKK, Li MKW. CYTOREDUCTIVE SURGERY IN MULTIDISCIPLINARY TREATMENT OF ADVANCED HEPATOCELLULAR CARCINOMA. ANZ J Surg 2008;78:504-7. [DOI: 10.1111/j.1445-2197.2008.04544.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
60 Cavaliere F, De Simone M, Virzì S, Deraco M, Rossi CR, Garofalo A, Di Filippo F, Giannarelli D, Vaira M, Valle M. Prognostic factors and oncologic outcome in 146 patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: Italian multicenter study S.I.T.I.L.O. Eur J Surg Oncol. 2011;37:148-154. [PMID: 21093205 DOI: 10.1016/j.ejso.2010.10.014] [Cited by in Crossref: 90] [Cited by in F6Publishing: 84] [Article Influence: 7.5] [Reference Citation Analysis]
61 Gammon DC, Dutton T, Piperdi B, Zybert J, Wolfe SH, Nguyen E, Sbat D, Pillarisetty VG, Sullivan M, Whalen GF. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in the treatment of peritoneal carcinomatosis. Am J Health Syst Pharm 2009;66:1186-90. [PMID: 19535657 DOI: 10.2146/ajhp080019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
62 Li D, Henker R, Zhang F. Perianesthesia Measurement During Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Procedure: A Case Report and Review of the Literature. Journal of PeriAnesthesia Nursing 2019;34:198-205. [DOI: 10.1016/j.jopan.2017.09.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
63 Burnett A, Lecompte MA, Trabulsi N, Dubé P, Gervais MK, Trilling B, Cloutier AS, Sideris L. Peritoneal carcinomatosis index predicts survival in colorectal patients undergoing HIPEC using oxaliplatin: a retrospective single-arm cohort study. World J Surg Oncol 2019;17:83. [PMID: 31092250 DOI: 10.1186/s12957-019-1618-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
64 Lee DH, Oh SY, Lee YR, Huh SJ, Yoon HH, Kim SH, Lee S, Lee JH, Kim Y, Kim HJ. A Phase II Study of Modified FOLFOX4 for Colorectal Cancer Patients with Peritoneal Carcinomatosis. Cancer Res Treat. 2011;43:225-230. [PMID: 22247707 DOI: 10.4143/crt.2011.43.4.225] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
65 Vicente D, Avital I, Stojadinovic A. Role of multi-modality therapy in peritoneal carcinomatosis and visceral metastasis: a case report and review of the literature. World J Surg Oncol 2015;13:2. [PMID: 26264074 DOI: 10.1186/1477-7819-13-2] [Reference Citation Analysis]
66 Piso P, Dahlke MH, Ghali N, Iesalnieks I, Loss M, Popp F, von Breitenbuch P, Agha A, Lang SA, Kullmann F, Schlitt HJ. Multimodality treatment of peritoneal carcinomatosis from colorectal cancer: first results of a new German centre for peritoneal surface malignancies. Int J Colorectal Dis 2007;22:1295-300. [DOI: 10.1007/s00384-007-0313-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
67 Losa F, Barrios P, Salazar R, Torres-melero J, Benavides M, Massuti T, Ramos I, Aranda E. Cytoreductive surgery and intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis from colorectal origin. Clin Transl Oncol 2014;16:128-40. [DOI: 10.1007/s12094-013-1053-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
68 Gutowski M, Framery B, Boonstra MC, Garambois V, Quenet F, Dumas K, Scherninski F, Cailler F, Vahrmeijer AL, Pèlegrin A. SGM-101: An innovative near-infrared dye-antibody conjugate that targets CEA for fluorescence-guided surgery. Surgical Oncology 2017;26:153-62. [DOI: 10.1016/j.suronc.2017.03.002] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 6.2] [Reference Citation Analysis]
69 Blakely AM, Lafaro KJ, Eng OS, Ituarte PHG, Fakih M, Lee B, Raoof M. The Association of Tumor Laterality and Survival After Cytoreduction for Colorectal Carcinomatosis. J Surg Res 2020;248:20-7. [PMID: 31841733 DOI: 10.1016/j.jss.2019.10.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
70 Ryan AE, Colleran A, O'Gorman A, O'Flynn L, Pindjacova J, Lohan P, O'Malley G, Nosov M, Mureau C, Egan LJ. Targeting colon cancer cell NF-κB promotes an anti-tumour M1-like macrophage phenotype and inhibits peritoneal metastasis. Oncogene. 2015;34:1563-1574. [PMID: 24704833 DOI: 10.1038/onc.2014.86] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
71 Ishida H, Kumamoto K, Ishibashi K, Hatano S, Matsuzawa T, Okada N, Kumagai Y, Baba H, Haga N. Should isolated peritoneal carcinomatosis from colorectal cancer be sub-classified into stage IVB in era of modern chemotherapy? Tech Coloproctol 2013;17:647-52. [PMID: 23389285 DOI: 10.1007/s10151-012-0972-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
72 Martin D, Grass F, Deo SVS, Ashwin KR, Maheshwari A, Hübner M, Somashekhar SP. Current Opinion on Peritoneal Carcinomatosis Treatment: a Survey of the Indian Society of Peritoneal Surface Malignancies (ISPSM). J Gastrointest Cancer 2021;52:1061-6. [PMID: 33073299 DOI: 10.1007/s12029-020-00538-1] [Reference Citation Analysis]
73 Pamela K, Matthias Z, Reinhold KR, Julia P, Peter M, Alexander P, Dietmar Ö. Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): a Single-Center Experience in Austria. J Gastrointest Surg 2018;22:884-93. [PMID: 29363016 DOI: 10.1007/s11605-017-3661-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
74 Vásquez Jiménez W, González Bayón L, García-Sabrido JL, González Moreno S. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignant disease. Clin Transl Oncol 2010;12:794-804. [PMID: 21156410 DOI: 10.1007/s12094-010-0601-x] [Reference Citation Analysis]
75 Zak Y, Moore HG, Ghosh BC. Patterns of recurrence of colorectal cancer. J Surg Oncol. 2008;97:1-2. [PMID: 17680636 DOI: 10.1002/jso.20882] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
76 Solon JG, O'Neill M, Chang KH, Deady S, Cahill R, Moran B, Shields C, Mulsow J. An 18 year population-based study on site of origin and outcome of patients with peritoneal malignancy in Ireland. Eur J Surg Oncol 2017;43:1924-31. [PMID: 28583791 DOI: 10.1016/j.ejso.2017.05.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
77 Lehmann K, Rickenbacher A, Jang JH, Oberkofler CE, Vonlanthen R, von Boehmer L, Humar B, Graf R, Gertsch P, Clavien PA. New insight into hyperthermic intraperitoneal chemotherapy: induction of oxidative stress dramatically enhanced tumor killing in in vitro and in vivo models. Ann Surg 2012;256:730-7; discussion 737-8. [PMID: 23095616 DOI: 10.1097/SLA.0b013e3182737517] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
78 Marin D, Catalano C, Baski M, Di Martino M, Geiger D, Di Giorgio A, Sibio S, Passariello R. 64-Section multi-detector row CT in the preoperative diagnosis of peritoneal carcinomatosis: correlation with histopathological findings. Abdom Imaging 2010;35:694-700. [DOI: 10.1007/s00261-008-9464-9] [Cited by in Crossref: 55] [Cited by in F6Publishing: 41] [Article Influence: 4.2] [Reference Citation Analysis]
79 Bin Traiki T, Fisher O, Valle S, Parikh R, Kozman M, Glenn D, Power M, Liauw W, Alzahrani N, Morris D. Percutaneous lung ablation of pulmonary recurrence may improve survival in selected patients undergoing cytoreductive surgery for colorectal cancer with peritoneal carcinomatosis. European Journal of Surgical Oncology (EJSO) 2017;43:1939-48. [DOI: 10.1016/j.ejso.2017.08.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
80 Chua TC, Esquivel J, Pelz JO, Morris DL. Summary of current therapeutic options for peritoneal metastases from colorectal cancer. J Surg Oncol. 2013;107:566-573. [PMID: 22688776 DOI: 10.1002/jso.23189] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 5.2] [Reference Citation Analysis]
81 van de Poll MC, Klaver YL, Lemmens VE, Leenders BJ, Nienhuijs SW, de Hingh IH. C-reactive protein concentration is associated with prognosis in patients suffering from peritoneal carcinomatosis of colorectal origin. Int J Colorectal Dis. 2011;26:1067-1073. [PMID: 21476028 DOI: 10.1007/s00384-011-1187-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
82 Lim SJ, Cormier JN, Feig BW, Mansfield PF, Benjamin RS, Griffin JR, Chase JL, Pisters PWT, Pollock RE, Hunt KK. Toxicity and Outcomes Associated with Surgical Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Patients with Sarcomatosis. Ann Surg Oncol 2007;14:2309-18. [DOI: 10.1245/s10434-007-9463-z] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 3.1] [Reference Citation Analysis]
83 Pinto A, Pocard M. Hyperthermic intraperitoneal chemotherapy with cisplatin and mitomycin C for colorectal cancer peritoneal metastases: A systematic review of the literature. Pleura Peritoneum. 2019;4:20190006. [PMID: 31388562 DOI: 10.1515/pp-2019-0006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
84 Tan B, Huang L, Wu Y, Liao J. Advances and trends of hydrogel therapy platform in localized tumor treatment: A review. J Biomed Mater Res A 2021;109:404-25. [PMID: 32681742 DOI: 10.1002/jbm.a.37062] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
85 Benlahfid M, Traboulsi W, Sergent F, Benharouga M, Elhattabi K, Erguibi D, Karkouri M, Elattar H, Fadil A, Fahmi Y, Aboussaouira T, Alfaidy N. Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) and its receptor PROKR2 are associated to human colorectal cancer progression and peritoneal carcinomatosis. Cancer Biomark 2018;21:345-54. [PMID: 29226856 DOI: 10.3233/CBM-170499] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
86 Franko J, Ibrahim Z, Gusani NJ, Holtzman MP, Bartlett DL, Zeh HJ. Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis. Cancer. 2010;116:3756-3762. [PMID: 20564081 DOI: 10.1002/cncr.25116] [Cited by in Crossref: 210] [Cited by in F6Publishing: 189] [Article Influence: 17.5] [Reference Citation Analysis]
87 Kianmanesh R, Scaringi S, Sabate JM, Castel B, Pons-Kerjean N, Coffin B, Hay JM, Flamant Y, Msika S. Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases. Ann Surg. 2007;245:597-603. [PMID: 17414609 DOI: 10.1097/01.sla.0000255561.87771.11] [Cited by in Crossref: 120] [Cited by in F6Publishing: 112] [Article Influence: 8.0] [Reference Citation Analysis]
88 Carpizo DR, D’angelica M. Liver Resection for Metastatic Colorectal Cancer in the Presence of Extrahepatic Disease. Ann Surg Oncol 2009;16:2411-21. [DOI: 10.1245/s10434-009-0493-6] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
89 Dunn D. Surgical treatment of patients with peritoneal surface malignancy: cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. J Wound Ostomy Continence Nurs 2010;37:379-85. [PMID: 20644370 DOI: 10.1097/WON.0b013e3181e399fe] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
90 Salamanca IMG, Jaime MTE, Penco JMM, Martínez JS. Role of Peritoneal Cytology in Patients with Early Stage Colorectal Cancer. Pathol Oncol Res 2020;26:1325-9. [PMID: 31401769 DOI: 10.1007/s12253-019-00706-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
91 de Cuba EM, de Hingh IH, Sluiter NR, Kwakman R, Coupé VM, Beliën JA, Verwaal VJ, Meijerink WJ, Delis-van Diemen PM, Bonjer HJ, Meijer GA, Te Velde EA. Angiogenesis-Related Markers and Prognosis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer. Ann Surg Oncol 2016;23:1601-8. [PMID: 26727921 DOI: 10.1245/s10434-015-5023-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
92 Alzahrani NA, Valle SJ, Fisher OM, Sugarbaker PH, Yonemura Y, Glehen O, Goere D, Honore C, Brigand C, de Hingh I, Verwaal VJ, Deraco M, Baratti D, Kusamura S, Pocard M, Piso P, Maerz L, Marchal F, Moran B, Levine EA, Dumont F, Pezet D, Abboud K, Kozman MA, Liauw W, Morris DL; Peritoneal Surface Oncology Group International (PSOGI) and Big-RENAPE groups. Iterative cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A multi-institutional experience. J Surg Oncol. 2019;119:336-346. [PMID: 30554404 DOI: 10.1002/jso.25277] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
93 García-matus R, Hernández-hernández CA, Leyva-garcía O, Vásquez-ciriaco S, Flores-ayala G, Navarro-hernández Q, Pérez-bustamante G, Valencia-mijares NM, Esquivel J. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Peritoneal Carcinomatosis: Initial Experience in Oaxaca, Mexico. The American Surgeon 2012;78:942-6. [DOI: 10.1177/000313481207800932] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
94 Elias D, Honoré C, Dumont F, Ducreux M, Boige V, Malka D, Burtin P, Dromain C, Goéré D. Results of Systematic Second-look Surgery Plus HIPEC in Asymptomatic Patients Presenting a High Risk of Developing Colorectal Peritoneal Carcinomatosis. Annals of Surgery 2011;254:289-93. [DOI: 10.1097/sla.0b013e31822638f6] [Cited by in Crossref: 159] [Cited by in F6Publishing: 51] [Article Influence: 14.5] [Reference Citation Analysis]
95 Dong L, Li K, Peng T. Diagnostic value of diffusion-weighted imaging/magnetic resonance imaging for peritoneal metastasis from malignant tumor: A systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e24251. [PMID: 33592867 DOI: 10.1097/MD.0000000000024251] [Reference Citation Analysis]
96 Chung T, Chang HJ, Jung KH, Park S, Lim S, Choi HS, Jeong S. Role of surgery in the treatment of ovarian metastases from colorectal cancer: Ovary Metastases From Colorectal Cancer. J Surg Oncol 2009;100:570-4. [DOI: 10.1002/jso.21382] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
97 Qian J, LeSavage BL, Hubka KM, Ma C, Natarajan S, Eggold JT, Xiao Y, Fuh KC, Krishnan V, Enejder A, Heilshorn SC, Dorigo O, Rankin EB. Cancer-associated mesothelial cells promote ovarian cancer chemoresistance through paracrine osteopontin signaling. J Clin Invest 2021;131:146186. [PMID: 34396988 DOI: 10.1172/JCI146186] [Reference Citation Analysis]
98 Prasanna T, Wong R, Price T, Shapiro J, Tie J, Wong HL, Nott L, Roder D, Lee M, Kosmider S, Jalali A, Burge M, Padbury R, Maddern G, Carruthers S, Moore J, Sorich M, Karapetis CS, Gibbs P, Yip D. Metastasectomy and BRAF mutation; an analysis of survival outcome in metastatic colorectal cancer. Curr Probl Cancer 2021;45:100637. [PMID: 32826083 DOI: 10.1016/j.currproblcancer.2020.100637] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
99 Confuorto G, Giuliano M, Grimaldi A, Viviano C. Peritoneal carcinomatosis from colorectal cancer: HIPEC? Surgical Oncology 2007;16:149-52. [DOI: 10.1016/j.suronc.2007.10.026] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
100 Aarts F, Koppe MJ, Hendriks T, van Eerd JE, Oyen WJ, Boerman OC, Bleichrodt RP. Timing of adjuvant radioimmunotherapy after cytoreductive surgery in experimental peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol 2007;14:533-40. [PMID: 17122992 DOI: 10.1245/s10434-006-9247-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
101 Ottolino-Perry K, Tang N, Head R, Ng C, Arulanandam R, Angarita FA, Acuna SA, Chen Y, Bell J, Dacosta RS, McCart JA. Tumor vascularization is critical for oncolytic vaccinia virus treatment of peritoneal carcinomatosis. Int J Cancer 2014;134:717-30. [PMID: 23893655 DOI: 10.1002/ijc.28395] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
102 Redden M, Riddell A. Foreign body reaction to spilled gastric contents mimicking peritoneal metastasis of colorectal cancer. Journal of Surgical Case Reports 2022;2022:rjab615. [DOI: 10.1093/jscr/rjab615] [Reference Citation Analysis]
103 Tabrizian P, Jibara G, Shrager B, Franssen B, Yang M, Sarpel U, Hiotis S, Labow D. Outcomes for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the elderly. Surgical Oncology 2013;22:184-9. [DOI: 10.1016/j.suronc.2013.06.001] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
104 Fields AC, Lu PW, Li GZ, Welten V, Jolissaint JS, Vierra BM, Saadat LV, Larson AC, Atkinson RB, Melnitchouk N. Current practices and future steps for hyperthermic intraperitoneal chemotherapy. Curr Probl Surg 2020;57:100727. [PMID: 32151327 DOI: 10.1016/j.cpsurg.2019.100727] [Reference Citation Analysis]
105 Roviello F, Marrelli D, Neri A, Cerretani D, de Manzoni G, Pedrazzani C, Cioppa T, Nastri G, Giorgi G, Pinto E. Treatment of peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion (IHCP): postoperative outcome and risk factors for morbidity. World J Surg. 2006;30:2033-2040. [PMID: 17006608 DOI: 10.1007/s00268-006-0038-0] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 3.9] [Reference Citation Analysis]
106 van Vugt JL, Braam HJ, van Oudheusden TR, Vestering A, Bollen TL, Wiezer MJ, de Hingh IH, van Ramshorst B, Boerma D. Skeletal Muscle Depletion is Associated with Severe Postoperative Complications in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Cancer. Ann Surg Oncol 2015;22:3625-31. [PMID: 25672564 DOI: 10.1245/s10434-015-4429-z] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 6.6] [Reference Citation Analysis]
107 Saad-Hossne R, Hossne WS, Montenegro MR. Effects of intraperitoneal injection of phenol, glycerin and acetic acid on neoplastic ascitis in guinea pigs. Acta Cir Bras 2008;23:501-3. [PMID: 19030748 DOI: 10.1590/s0102-86502008000600006] [Reference Citation Analysis]
108 Bhagwandin SB, Salti GI. Hepatocellular carcinoma with peritoneal metastasis treated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy. Tumori 2015;101:e1-3. [PMID: 25702649 DOI: 10.5301/tj.5000197] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
109 Gervais MK, Dubé P, McConnell Y, Drolet P, Mitchell A, Sideris L. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis arising from colorectal cancer. J Surg Oncol 2013;108:438-43. [PMID: 24018983 DOI: 10.1002/jso.23431] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
110 Beagan JJ, Sluiter NR, Bach S, Eijk PP, Vlek SL, Heideman DAM, Kusters M, Pegtel DM, Kazemier G, van Grieken NCT, Ylstra B, Tuynman JB. Circulating Tumor DNA as a Preoperative Marker of Recurrence in Patients with Peritoneal Metastases of Colorectal Cancer: A Clinical Feasibility Study. J Clin Med 2020;9:E1738. [PMID: 32512811 DOI: 10.3390/jcm9061738] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
111 Klaver YL, Lemmens VE, Nienhuijs SW, Luyer MD, de Hingh IH. Peritoneal carcinomatosis of colorectal origin: Incidence, prognosis and treatment options. World J Gastroenterol 2012; 18(39): 5489-5494 [PMID: 23112540 DOI: 10.3748/wjg.v18.i39.5489] [Cited by in CrossRef: 70] [Cited by in F6Publishing: 65] [Article Influence: 7.0] [Reference Citation Analysis]
112 de Cuba EMV, Kwakman R, van Egmond M, Bosch LJW, Bonjer HJ, Meijer GA, te Velde EA. Understanding molecular mechanisms in peritoneal dissemination of colorectal cancer: Future possibilities for personalised treatment by use of biomarkers. Virchows Arch 2012;461:231-43. [DOI: 10.1007/s00428-012-1287-y] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
113 Sun CF, Tan ZH, Shen C, Mao XY, Ge CC, Gao Y, Hu CH. Distribution Characteristics of Colorectal Peritoneal Carcinomatosis Based on the Positron Emission Tomography/Peritoneal Cancer Index. Cancer Biother Radiopharm 2020. [PMID: 32833546 DOI: 10.1089/cbr.2020.3733] [Reference Citation Analysis]
114 Abuzar SM, Ahn JH, Park KS, Park EJ, Baik SH, Hwang SJ. Pharmacokinetic Profile and Anti-Adhesive Effect of Oxaliplatin-PLGA Microparticle-Loaded Hydrogels in Rats for Colorectal Cancer Treatment. Pharmaceutics 2019;11:E392. [PMID: 31387217 DOI: 10.3390/pharmaceutics11080392] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
115 Rampone B, Schiavone B, Martino A, Confuorto G. Current role of hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis from colorectal cancer. World J Gastroenterol 2010; 16(11): 1299-1302 [PMID: 20238394 DOI: 10.3748/wjg.v16.i11.1299] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
116 Lin EK, Hsieh MC, Chen CH, Lu YJ, Wu SY. Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer with peritoneal metastasis. Medicine (Baltimore). 2016;95:e5522. [PMID: 28033247 DOI: 10.1097/md.0000000000005522] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
117 Narasimhan V, Britto M, Pham T, Warrier S, Naik A, Lynch AC, Michael M, Tie J, Ramsay R, Heriot A. Evolution of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: 8-Year Single-Institutional Experience. Dis Colon Rectum 2019;62:1195-203. [PMID: 31490828 DOI: 10.1097/DCR.0000000000001456] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
118 Cao C, Yan TD, Black D, Morris DL. A systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol. 2009;16:2152-2165. [PMID: 19434455 DOI: 10.1245/s10434-009-0487-4] [Cited by in Crossref: 158] [Cited by in F6Publishing: 141] [Article Influence: 12.2] [Reference Citation Analysis]
119 Cashin PH, Graf W, Nygren P, Mahteme H. Intraoperative hyperthermic versus postoperative normothermic intraperitoneal chemotherapy for colonic peritoneal carcinomatosis: a case-control study. Ann Oncol. 2012;23:647-652. [PMID: 21685413 DOI: 10.1093/annonc/mdr301] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
120 Zhang H, Dai W, Fu C, Yan X, Stemmer A, Tong T, Cai G. Diagnostic value of whole-body MRI with diffusion-weighted sequence for detection of peritoneal metastases in colorectal malignancy. Cancer Biol Med 2018;15:165-70. [PMID: 29951340 DOI: 10.20892/j.issn.2095-3941.2017.0162] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
121 Matsuzaki S, Azuar AS, Mage G, Canis M. Impact of the surgical peritoneal environment on pre-implanted tumors on a molecular level: a syngeneic mouse model. J Surg Res 2010;162:79-87. [PMID: 19524269 DOI: 10.1016/j.jss.2008.12.026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
122 Rivard JD, Temple WJ, Mcconnell YJ, Sultan H, Mack LA. Preoperative computed tomography does not predict resectability in peritoneal carcinomatosis. The American Journal of Surgery 2014;207:760-5. [DOI: 10.1016/j.amjsurg.2013.12.024] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
123 Kranenburg O, van der Speeten K, de Hingh I. Peritoneal Metastases From Colorectal Cancer: Defining and Addressing the Challenges. Front Oncol 2021;11:650098. [PMID: 33816304 DOI: 10.3389/fonc.2021.650098] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
124 Bhagwandin S, Naffouje S, Salti G. Utility of Chemoresponse Assay in Patients Undergoing Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy. Ann Surg Oncol 2015;22:2573-7. [PMID: 25572680 DOI: 10.1245/s10434-014-4330-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
125 Sluiter NR, Tuynman JB. ASO Author Reflections: Advanced Imaging Allows Better Detection of Peritoneal Metastases. Ann Surg Oncol 2019;26:165-6. [PMID: 30474765 DOI: 10.1245/s10434-018-7083-4] [Reference Citation Analysis]
126 Maggiori L, Goéré D, Viana B, Tzanis D, Dumont F, Honoré C, Eveno C, Elias D. Should patients with peritoneal carcinomatosis of colorectal origin with synchronous liver metastases be treated with a curative intent? A case-control study. Ann Surg. 2013;258:116-121. [PMID: 23207243 DOI: 10.1097/sla.0b013e3182778089] [Cited by in Crossref: 70] [Cited by in F6Publishing: 27] [Article Influence: 7.8] [Reference Citation Analysis]
127 Cramer G, Lewis R, Gymarty A, Hagan S, Mickler M, Evans S, Punekar SR, Shuman L, Simone CB, Hahn SM, Busch TM, Fraker D, Cengel KA. Preclinical Evaluation of Cetuximab and Benzoporphyrin Derivative‐Mediated Intraperitoneal Photodynamic Therapy in a Canine Model. Photochem Photobiol 2020;96:684-91. [DOI: 10.1111/php.13247] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
128 Mohamed A, Jiang R, Philip PA, Diab M, Behera M, Wu C, Alese O, Shaib WL, Gaines TM, Balch GG, El-Rayes BF, Akce M. High-Risk Features Are Prognostic in dMMR/MSI-H Stage II Colon Cancer. Front Oncol 2021;11:755113. [PMID: 34760701 DOI: 10.3389/fonc.2021.755113] [Reference Citation Analysis]
129 Gusani NJ, Cho SW, Colovos C, Seo S, Franko J, Richard SD, Edwards RP, Brown CK, Holtzman MP, Zeh HJ. Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center. Ann Surg Oncol. 2008;15:754-763. [PMID: 18080166 DOI: 10.1245/s10434-007-9701-4] [Cited by in Crossref: 129] [Cited by in F6Publishing: 123] [Article Influence: 8.6] [Reference Citation Analysis]
130 Rentsch M, Schiergens T, Khandoga A, Werner J. Surgery for Colorectal Cancer - Trends, Developments, and Future Perspectives. Visc Med 2016;32:184-91. [PMID: 27493946 DOI: 10.1159/000446490] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
131 Sjo OH, Berg M, Merok MA, Kolberg M, Svindland A, Lothe RA, Nesbakken A. Peritoneal carcinomatosis of colon cancer origin: highest incidence in women and in patients with right-sided tumors. J Surg Oncol. 2011;104:792-797. [PMID: 21547915 DOI: 10.1002/jso.21959] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
132 Franko J. Therapeutic efficacy of systemic therapy for colorectal peritoneal carcinomatosis: Surgeon's perspective. Pleura Peritoneum 2018;3:20180102. [PMID: 30911652 DOI: 10.1515/pp-2018-0102] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
133 Hornung M, Werner JM, Schlitt HJ. Applications of hyperthermic intraperitoneal chemotherapy for metastatic colorectal cancer. Expert Rev Anticancer Ther 2017;17:841-50. [PMID: 28715968 DOI: 10.1080/14737140.2017.1357470] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
134 Ströhlein MA, Heiss MM. The trifunctional antibody catumaxomab in treatment of malignant ascites and peritoneal carcinomatosis. Future Oncol 2010;6:1387-94. [PMID: 20919824 DOI: 10.2217/fon.10.111] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
135 Saikia J, Deo S, Ray M, Mishra A, Bansal B, Bhoriwal S, Bhatnagar S, Mishra S, Bharti S, Kumar V, Kumar M. Learning Curve of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy – an Analysis of Critical Perioperative and Surgical Outcomes among 155 Peritoneal Surface Malignancy Patients Treated at a Tertiary Care Cancer Centre. Clinical Oncology 2022. [DOI: 10.1016/j.clon.2022.03.003] [Reference Citation Analysis]
136 Mikuła-Pietrasik J, Uruski P, Tykarski A, Książek K. The peritoneal "soil" for a cancerous "seed": a comprehensive review of the pathogenesis of intraperitoneal cancer metastases. Cell Mol Life Sci 2018;75:509-25. [PMID: 28956065 DOI: 10.1007/s00018-017-2663-1] [Cited by in Crossref: 65] [Cited by in F6Publishing: 60] [Article Influence: 13.0] [Reference Citation Analysis]
137 Cloutier A, Faron M, Honoré C, Goéré D, Dumont F, Vittadello F, Élias D. Second-look surgery plus HIPEC for patients with colorectal cancer at high risk of peritoneal carcinomatosis: Should we resect the initial anastomosis? An observational study. European Journal of Surgical Oncology (EJSO) 2015;41:1068-73. [DOI: 10.1016/j.ejso.2015.02.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
138 Hompes D, Aalbers A, Boot H, van Velthuysen ML, Vogel W, Prevoo W, van Tinteren H, Verwaal V. A prospective pilot study to assess neoadjuvant chemotherapy for unresectable peritoneal carcinomatosis from colorectal cancer. Colorectal Dis. 2014;16:O264-O272. [PMID: 24433532 DOI: 10.1111/codi.12560] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
139 Nassour I, Polanco PM. Current Management of Peritoneal Carcinomatosis From Colorectal Cancer: The Role of Cytoreductive Surgery and Hyperthermic Peritoneal Chemoperfusion. Curr Colorectal Cancer Rep 2017;13:144-53. [PMID: 28890671 DOI: 10.1007/s11888-017-0361-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
140 Matsuzaki S, Bourdel N, Darcha C, Déchelotte PJ, Bazin J, Pouly J, Mage G, Canis M. Molecular mechanisms underlying postoperative peritoneal tumor dissemination may differ between a laparotomy and carbon dioxide pneumoperitoneum: a syngeneic mouse model with controlled respiratory support. Surg Endosc 2009;23:705-14. [DOI: 10.1007/s00464-008-0041-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
141 Shi R, Zhao K, Wang T, Yuan J, Zhang D, Xiang W, Qian J, Luo N, Zhou Y, Tang B, Li C, Miao H. 5-aza-2'-deoxycytidine potentiates anti-tumor immunity in colorectal peritoneal metastasis by modulating ABC A9-mediated cholesterol accumulation in macrophages. Theranostics 2022;12:875-90. [PMID: 34976218 DOI: 10.7150/thno.66420] [Reference Citation Analysis]
142 von Riedenauer WB, Janjua SA, Kwon DS, Zhang Z, Velanovich V. Immunohistochemical identification of primary peritoneal serous cystadenocarcinoma mimicking advanced colorectal carcinoma: a case report. J Med Case Rep 2007;1:150. [PMID: 18036260 DOI: 10.1186/1752-1947-1-150] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
143 Agalar C, Sokmen S, Arslan C, Altay C, Basara I, Canda AE, Obuz F. The impact of sarcopenia on morbidity and long-term survival among patients with peritoneal metastases of colorectal origin treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a 10-year longitudinal analysis of a single-center experience. Tech Coloproctol 2020;24:301-8. [PMID: 32080800 DOI: 10.1007/s10151-020-02159-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
144 Gelli M, Huguenin JF, de Baere T, Benhaim L, Mariani A, Boige V, Malka D, Sourouille I, Ducreux M, Elias D, Goéré D. Peritoneal and extraperitoneal relapse after previous curative treatment of peritoneal metastases from colorectal cancer: What survival can we expect? European Journal of Cancer 2018;100:94-103. [DOI: 10.1016/j.ejca.2018.04.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
145 Sugahara KN, Scodeller P, Braun GB, de Mendoza TH, Yamazaki CM, Kluger MD, Kitayama J, Alvarez E, Howell SB, Teesalu T, Ruoslahti E, Lowy AM. A tumor-penetrating peptide enhances circulation-independent targeting of peritoneal carcinomatosis. J Control Release 2015;212:59-69. [PMID: 26071630 DOI: 10.1016/j.jconrel.2015.06.009] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 7.1] [Reference Citation Analysis]
146 Bir A, Tan W, Wilding GE, Lombardo J, Fakih MG. 5-fluorouracil, leucovorin and oxaliplatin plus bevacizumab in the first-line treatment of metastatic colorectal cancer: a single-institute study. Oncology. 2007;72:4-9. [PMID: 17971679 DOI: 10.1159/000110546] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
147 Eveno C, Mojica K, Ady JW, Thorek DL, Longo V, Belin LJ, Gholami S, Johnsen C, Zanzonico P, Chen N, Yu T, Szalay AA, Fong Y. Gene therapy using therapeutic and diagnostic recombinant oncolytic vaccinia virus GLV-1h153 for management of colorectal peritoneal carcinomatosis. Surgery 2015;157:331-7. [PMID: 25616946 DOI: 10.1016/j.surg.2014.09.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
148 López-Rojo I, Olmedillas-López S, Villarejo Campos P, Domínguez Prieto V, Barambio Buendía J, Cortés Guiral D, García-Arranz M, García-Olmo D. Liquid biopsy in peritoneal fluid and plasma as a prognostic factor in advanced colorectal and appendiceal tumors after complete cytoreduction and hyperthermic intraperitoneal chemotherapy. Ther Adv Med Oncol 2020;12:1758835920981351. [PMID: 33425029 DOI: 10.1177/1758835920981351] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
149 Metildi CA, Kaushal S, Luiken GA, Talamini MA, Hoffman RM, Bouvet M. Fluorescently labeled chimeric anti-CEA antibody improves detection and resection of human colon cancer in a patient-derived orthotopic xenograft (PDOX) nude mouse model. J Surg Oncol 2014;109:451-8. [PMID: 24249594 DOI: 10.1002/jso.23507] [Cited by in Crossref: 115] [Cited by in F6Publishing: 108] [Article Influence: 12.8] [Reference Citation Analysis]
150 Sodek KL, Murphy KJ, Brown TJ, Ringuette MJ. Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis. Cancer Metastasis Rev. 2012;31:397-414. [PMID: 22527451 DOI: 10.1007/s10555-012-9351-2] [Cited by in Crossref: 86] [Cited by in F6Publishing: 84] [Article Influence: 8.6] [Reference Citation Analysis]
151 Sandoval P, Jiménez-Heffernan JA, Rynne-Vidal Á, Pérez-Lozano ML, Gilsanz Á, Ruiz-Carpio V, Reyes R, García-Bordas J, Stamatakis K, Dotor J, Majano PL, Fresno M, Cabañas C, López-Cabrera M. Carcinoma-associated fibroblasts derive from mesothelial cells via mesothelial-to-mesenchymal transition in peritoneal metastasis. J Pathol 2013;231:517-31. [PMID: 24114721 DOI: 10.1002/path.4281] [Cited by in Crossref: 86] [Cited by in F6Publishing: 77] [Article Influence: 10.8] [Reference Citation Analysis]
152 Monzo M, Santasusagna S, Moreno I, Martinez F, Hernández R, Muñoz C, Castellano JJ, Moreno J, Navarro A. Exosomal microRNAs isolated from plasma of mesenteric veins linked to liver metastases in resected patients with colon cancer. Oncotarget 2017;8:30859-69. [PMID: 28415718 DOI: 10.18632/oncotarget.16103] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
153 Mikuła-Pietrasik J, Sosińska P, Maksin K, Kucińska MG, Piotrowska H, Murias M, Woźniak A, Szpurek D, Książek K. Colorectal cancer-promoting activity of the senescent peritoneal mesothelium. Oncotarget 2015;6:29178-95. [PMID: 26284488 DOI: 10.18632/oncotarget.4932] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
154 Roy P, Mignet N, Pocard M, Boudy V. Drug delivery systems to prevent peritoneal metastasis after surgery of digestives or ovarian carcinoma: A review. International Journal of Pharmaceutics 2021;592:120041. [DOI: 10.1016/j.ijpharm.2020.120041] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
155 Lo Dico R, Faron M, Yonemura Y, Glehen O, Pocard M, Sardi A, Hübner M, Baratti D, Liberale G, Kartheuser A, de Hingh I, Sugarbaker P, Ceelen W, Moran B, Robella M, Quenet F, Sideris L, Goere D, Limbert M, Sammartino P, Morris D; PSOGI Working Group, BIG RENAPE Working Group. Combined liver resection and cytoreductive surgery with HIPEC for metastatic colorectal cancer: Results of a worldwide analysis of 565 patients from the Peritoneal Surface Oncology Group International (PSOGI). Eur J Surg Oncol 2021;47:89-100. [PMID: 32943276 DOI: 10.1016/j.ejso.2020.07.038] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
156 Klaver CE, Groenen H, Morton DG, Laurberg S, Bemelman WA, Tanis PJ; research committee of the European Society of Coloproctology. Recommendations and consensus on the treatment of peritoneal metastases of colorectal origin: A systematic review of national and international guidelines. Colorectal Dis. 2017;19:224-236. [PMID: 28008728 DOI: 10.1111/codi.13593] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 8.6] [Reference Citation Analysis]
157 Mei LJ, Wang LW, Huang CQ, Yang XJ, Li Y. Oral gastrografin radiography for the evaluation of the functional impact of peritoneal carcinomatosis: Correlation with clinicopathological findings. Mol Clin Oncol 2015;3:979-86. [PMID: 26623037 DOI: 10.3892/mco.2015.573] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
158 de Cuba EM, Verwaal VJ, de Hingh IH, van Mens LJ, Nienhuijs SW, Aalbers AG, Bonjer HJ, te Velde EA. Morbidity associated with colostomy reversal after cytoreductive surgery and HIPEC. Ann Surg Oncol 2014;21:883-90. [PMID: 24242680 DOI: 10.1245/s10434-013-3370-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
159 Klaver YL, Simkens LH, Lemmens VE, Koopman M, Teerenstra S, Bleichrodt RP, de Hingh IH, Punt CJ. Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy. Eur J Surg Oncol. 2012;38:617-623. [PMID: 22572106 DOI: 10.1016/j.ejso.2012.03.008] [Cited by in Crossref: 117] [Cited by in F6Publishing: 100] [Article Influence: 11.7] [Reference Citation Analysis]
160 Aarts F, Hendriks T, Boerman OC, Oyen WJ, Bleichrodt RP. Hyperthermia and Fibrinolytic Therapy Do Not Improve the Beneficial Effect of Radioimmunotherapy Following Cytoreductive Surgery in Rats with Peritoneal Carcinomatosis of Colorectal Origin. Cancer Biotherapy and Radiopharmaceuticals 2008;23:301-9. [DOI: 10.1089/cbr.2007.0455] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
161 Kwong MLM, Sampah MES, Bello BL, Sugarbaker PH. Port site metastases after minimally invasive resection for colorectal cancer: A retrospective study of 13 patients. Surgical Oncology 2019;29:20-4. [DOI: 10.1016/j.suronc.2019.02.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
162 Chouillard E, Greco V, Tsiminikakis N. Peritoneal carcinomatosis of colorectal origin: is it really an end-stage disease? Tech Coloproctol 2013;17:619-21. [PMID: 24061499 DOI: 10.1007/s10151-013-1063-2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
163 Zhao S, Wu W, Jiang Z, Tang F, Ding L, Xu W, Ruan L. Roles of ARID1A variations in colorectal cancer: a collaborative review. Mol Med 2022;28. [DOI: 10.1186/s10020-022-00469-6] [Reference Citation Analysis]
164 Aarts F, Bleichrodt RP, Oyen WJ, Boerman OC. Intracavitary radioimmunotherapy to treat solid tumors. Cancer Biother Radiopharm 2008;23:92-107. [PMID: 18298333 DOI: 10.1089/cbr.2007.0412] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
165 Tian R, Li M, Wang J, Yu M, Kong X, Feng Y, Chen Z, Li Y, Huang W, Wu W, Hong Z. An intracellularly activatable, fluorogenic probe for cancer imaging. Org Biomol Chem 2014;12:5365-74. [DOI: 10.1039/c4ob00297k] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
166 Baratti D, Kusamura S, Deraco M. The Fifth International Workshop on Peritoneal Surface Malignancy (Milan, Italy, December 4-6, 2006): methodology of disease-specific consensus. J Surg Oncol 2008;98:258-62. [PMID: 18726888 DOI: 10.1002/jso.21056] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
167 Guend H, Patel S, Nash GM. Abdominal metastases from colorectal cancer: intraperitoneal therapy. J Gastrointest Oncol 2015;6:693-8. [PMID: 26697203 DOI: 10.3978/j.issn.2078-6891.2015.078] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
168 Kuncewitch M, Levine EA, Shen P, Votanopoulos KI. The Role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Appendiceal Tumors and Colorectal Adenocarcinomas. Clin Colon Rectal Surg 2018;31:288-94. [PMID: 30186050 DOI: 10.1055/s-0038-1642052] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
169 Pinto A, Hobeika C, Philis A, Kirzin S, Carrère N, Ghouti L. Synchronous liver metastases and peritoneal carcinomatosis from colorectal cancer: different strategies for curative treatment? Langenbecks Arch Surg 2019;404:477-88. [PMID: 31025165 DOI: 10.1007/s00423-019-01787-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
170 Sluiter N, de Cuba E, Kwakman R, Kazemier G, Meijer G, Te Velde EA. Adhesion molecules in peritoneal dissemination: function, prognostic relevance and therapeutic options. Clin Exp Metastasis 2016;33:401-16. [PMID: 27074785 DOI: 10.1007/s10585-016-9791-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
171 Hagendoorn J, van Lammeren G, Boerma D, van der Beek E, Wiezer M, van Ramshorst B. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal and gastrointestinal origin shows acceptable morbidity and high survival. European Journal of Surgical Oncology (EJSO) 2009;35:833-7. [DOI: 10.1016/j.ejso.2008.10.006] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
172 Brown KGM, Ansari N, Solomon MJ, Austin KKS, Hamilton AER, Young CJ. Pelvic exenteration combined with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for advanced primary or recurrent colorectal cancer with peritoneal metastases. Colorectal Dis 2021;23:186-91. [PMID: 32978813 DOI: 10.1111/codi.15378] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
173 Ung L, Chua TC, Morris DL. Cure for peritoneal metastases? An evidence-based review. ANZ J Surg 2013;83:821-6. [PMID: 23809063 DOI: 10.1111/ans.12306] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
174 Watanabe K, Saito N, Sugito M, Ito M, Kobayashi A, Nishizawa Y. Incidence and predictive factors for pulmonary metastases after curative resection of colon cancer. Ann Surg Oncol 2013;20:1374-80. [PMID: 23196787 DOI: 10.1245/s10434-012-2747-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
175 de Jong LAW, Elekonawo FMK, de Reuver PR, Bremers AJA, de Wilt JHW, Jansman FGA, Ter Heine R, van Erp NP. Hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis: a clinical pharmacological perspective on a surgical procedure. Br J Clin Pharmacol 2019;85:47-58. [PMID: 30255585 DOI: 10.1111/bcp.13773] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
176 Mohamed F, Moran BJ. Morbidity and mortality with cytoreductive surgery and intraperitoneal chemotherapy: the importance of a learning curve. Cancer J. 2009;15:196-199. [PMID: 19556904 DOI: 10.1097/ppo.0b013e3181a58d56] [Cited by in Crossref: 76] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
177 Kerscher AG, Chua TC, Gasser M, Maeder U, Kunzmann V, Isbert C, Germer CT, Pelz JO. Impact of peritoneal carcinomatosis in the disease history of colorectal cancer management: a longitudinal experience of 2406 patients over two decades. Br J Cancer. 2013;108:1432-1439. [PMID: 23511564 DOI: 10.1038/bjc.2013.82] [Cited by in Crossref: 66] [Cited by in F6Publishing: 62] [Article Influence: 7.3] [Reference Citation Analysis]
178 de Cuba EM, Kwakman R, Knol DL, Bonjer HJ, Meijer GA, Te Velde EA. Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases: Systematic review of all literature and meta-analysis of observational studies. Cancer Treat Rev. 2013;39:321-327. [PMID: 23244778 DOI: 10.1016/j.ctrv.2012.11.003] [Cited by in Crossref: 74] [Cited by in F6Publishing: 72] [Article Influence: 7.4] [Reference Citation Analysis]
179 Weber T, Roitman M, Link KH. Current Status of Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy in Patients With Peritoneal Carcinomatosis From Colorectal Cancer. Clinical Colorectal Cancer 2012;11:167-76. [DOI: 10.1016/j.clcc.2012.01.001] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
180 Shi R, Xiang W, Kang X, Zhang L, Wang J, Miao H, He F. Alteration of Adaptive Immunity in a Colorectal Peritoneal Carcinomatosis Model. J Cancer 2019;10:367-77. [PMID: 30719130 DOI: 10.7150/jca.27947] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
181 Yang XJ, Li Y, al-shammaa Hassan AH, Yang GL, Liu SY, Lu YL, Zhang JW, Yonemura Y. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases. Ann Surg Oncol. 2009;16:345-351. [PMID: 19018599 DOI: 10.1245/s10434-008-0226-2] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
182 Ihemelandu CU, Shen P, Stewart JH, Votanopoulos K, Levine EA. Management of peritoneal carcinomatosis from colorectal cancer. Semin Oncol 2011;38:568-75. [PMID: 21810516 DOI: 10.1053/j.seminoncol.2011.05.011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
183 Gueorguiev AL, Mackey R, Kowdley GC, Esquivel J, Cunningham SC. Minimally invasive evaluation and treatment of colorectal liver metastases. Int J Surg Oncol 2011;2011:686030. [PMID: 22312518 DOI: 10.1155/2011/686030] [Reference Citation Analysis]
184 Aarts F, Hendriks T, Boerman OC, Koppe MJ, Oyen WJ, Bleichrodt RP. A comparison between radioimmunotherapy and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis of colonic origin in rats. Ann Surg Oncol 2007;14:3274-82. [PMID: 17653591 DOI: 10.1245/s10434-007-9509-2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 2.3] [Reference Citation Analysis]
185 Laks S, Schtrechman G, Adileh M, Ben-Yaacov A, Purim O, Ivanov V, Aderka D, Shacham-Shmueli E, Halpern N, Goren S, Perelson D, Nissan A. Repeat Cytoreductive Surgery and Intraperitoneal Chemotherapy for Colorectal Cancer Peritoneal Recurrences is Safe and Efficacious. Ann Surg Oncol 2021;28:5330-8. [PMID: 33591479 DOI: 10.1245/s10434-021-09684-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
186 Iafrate F, Ciolina M, Sammartino P, Baldassari P, Rengo M, Lucchesi P, Sibio S, Accarpio F, Di Giorgio A, Laghi A. Peritoneal carcinomatosis: imaging with 64-MDCT and 3T MRI with diffusion-weighted imaging. Abdom Imaging 2012;37:616-27. [DOI: 10.1007/s00261-011-9804-z] [Cited by in Crossref: 42] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
187 Macrì A, Saladino E, Bartolo V, Adamo V, Altavilla G, Mondello E, Condemi G, Sinardi A, Famulari C. Peritoneal carcinomatosis of colorectal origin. World J Gastrointest Oncol 2010; 2(2): 98-101 [PMID: 21160927 DOI: 10.4251/wjgo.v2.i2.98] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
188 Bai L, Wang F, Li ZZ, Ren C, Zhang DS, Zhao Q, Lu YX, Wang DS, Ju HQ, Qiu MZ, Wang ZQ, Wang FH, Xu RH. Chemotherapy plus bevacizumab versus chemotherapy plus cetuximab as first-line treatment for patients with metastatic colorectal cancer: Results of a registry-based cohort analysis. Medicine (Baltimore) 2016;95:e4531. [PMID: 28002313 DOI: 10.1097/MD.0000000000004531] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
189 Takemura N, Hasegawa K, Aoki T, Sakamoto Y, Sugawara Y, Makuuchi M, Kokudo N. Surgical resection of peritoneal or thoracoabdominal wall implants from hepatocellular carcinoma. Br J Surg. 2014;101:1017-1022. [PMID: 24828028 DOI: 10.1002/bjs.9489] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
190 Galema HA, Meijer RPJ, Lauwerends LJ, Verhoef C, Burggraaf J, Vahrmeijer AL, Hutteman M, Keereweer S, Hilling DE. Fluorescence-guided surgery in colorectal cancer; A review on clinical results and future perspectives. Eur J Surg Oncol 2021:S0748-7983(21)00755-1. [PMID: 34657780 DOI: 10.1016/j.ejso.2021.10.005] [Reference Citation Analysis]
191 López-Basave HN, Morales-Vásquez F, Ruiz Molina JM, González-Enciso A, Namendys-Silva SA, Medina Castro JM, Montalvo-Esquivel G, Herrera-Gómez A, De la Garza Salazar JG. Morbidity and mortality of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: national cancer institute, Mexico city, Mexico. ISRN Oncol 2011;2011:526384. [PMID: 22091420 DOI: 10.5402/2011/526384] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
192 Chua TC, Martin S, Saxena A, Liauw W, Yan TD, Zhao J, Lok I, Morris DL. Evaluation of the Cost-Effectiveness of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (Peritonectomy) at the St George Hospital Peritoneal Surface Malignancy Program. Annals of Surgery 2010;251:323-9. [DOI: 10.1097/sla.0b013e3181c9b53c] [Cited by in Crossref: 40] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
193 al-Shammaa HAH, Li Y, Yonemura Y. Current status and future strategies of cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. World J Gastroenterol 2008; 14(8): 1159-1166 [PMID: 18300340 DOI: 10.3748/wjg.14.1159] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 45] [Article Influence: 3.9] [Reference Citation Analysis]
194 Ozawa H, Kotake K, Kobayashi H, Sugihara K. Prognostic factors for peritoneal carcinomatosis originating from colorectal cancer: an analysis of 921 patients from a multi-institutional database. Surg Today 2014;44:1643-50. [DOI: 10.1007/s00595-013-0735-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
195 Vanounou T, Garfinkle R. Evaluation of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Origin in the Era of Value-Based Medicine. Ann Surg Oncol 2016;23:2556-61. [PMID: 26957499 DOI: 10.1245/s10434-016-5096-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
196 Enblad M, Graf W, Birgisson H. Risk factors for appendiceal and colorectal peritoneal metastases. Eur J Surg Oncol 2018;44:997-1005. [PMID: 29576463 DOI: 10.1016/j.ejso.2018.02.245] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
197 Jacoby H, Berger Y, Barda L, Sharif N, Zager Y, Lebedyev A, Gutman M, Hoffman A. Implications of Stoma Formation as Part of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. World J Surg 2018;42:2036-42. [PMID: 29302727 DOI: 10.1007/s00268-017-4450-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
198 Canbay E, Torun BC, Torun ES, Yonemura Y. Evolution of management in peritoneal surface malignancies. Ulus Cerrahi Derg 2016;32:203-7. [PMID: 27528813 DOI: 10.5152/UCD.2016.3375] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
199 Bourdel N, Matsuzaki S, Bazin JE, Pouly JL, Mage G, Canis M. Peritoneal tissue-oxygen tension during a carbon dioxide pneumoperitoneum in a mouse laparoscopic model with controlled respiratory support. Hum Reprod. 2007;22:1149-1155. [PMID: 17208946 DOI: 10.1093/humrep/del482] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
200 Varban O, Levine EA, Stewart JH, McCoy TP, Shen P. Outcomes associated with cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in colorectal cancer patients with peritoneal surface disease and hepatic metastases. Cancer. 2009;115:3427-3436. [PMID: 19499577 DOI: 10.1002/cncr.24385] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 3.5] [Reference Citation Analysis]
201 Klaver YL, Hendriks T, Lomme RM, Rutten HJ, Bleichrodt RP, de Hingh IH. Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery for peritoneal carcinomatosis in an experimental model. Br J Surg. 2010;97:1874-1880. [PMID: 20806291 DOI: 10.1002/bjs.7249] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.4] [Reference Citation Analysis]
202 Karakousis GC, Alexander HR. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancy. J Gastrointest Oncol 2016;7:1-2. [PMID: 26941978 DOI: 10.3978/j.issn.2078-6891.2015.133] [Reference Citation Analysis]
203 Canbay E, Yonemura Y. Management of Special Issues. Peritoneal Surface Malignancies. Cham: Springer International Publishing; 2015. pp. 57-80. [DOI: 10.1007/978-3-319-12937-2_4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
204 Imaizumi K, Nishizawa Y, Ikeda K, Tsukada Y, Sasaki T, Ito M. Prognostic Impact of Curative Resection for Peritoneal Recurrence of Colorectal Cancer. Ann Surg Oncol 2020;27:2487-97. [PMID: 32052301 DOI: 10.1245/s10434-020-08242-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
205 Ahmadpour S, Khodadust F, Hormati A, Eivaziatashbeik K. Pivotal Role of Peptides in Gastric Carcinoma: Diagnosis and Therapy. Int J Pept Res Ther 2021;27:503-25. [DOI: 10.1007/s10989-020-10104-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
206 Gunn AJ, Brechbiel MW, Choyke PL. The emerging role of molecular imaging and targeted therapeutics in peritoneal carcinomatosis. Expert Opinion on Drug Delivery 2007;4:389-402. [DOI: 10.1517/17425247.4.4.389] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
207 Berger Y, Jacoby H, Kaufmann MI, Ben-Yaacov A, Westreich G, Sharon I, Barda L, Sharif N, Nadler R, Horesh N, Nissan A, Gutman M, Hoffman A. Correlation Between Intraoperative and Pathological Findings for Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Ann Surg Oncol 2019;26:1103-9. [PMID: 30746598 DOI: 10.1245/s10434-019-07219-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
208 Hall NC, Ruutiainen AT. Colorectal Cancer: Imaging Conundrums. Surg Oncol Clin N Am. 2018;27:289-302. [PMID: 29496090 DOI: 10.1016/j.soc.2017.11.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
209 Ito F, Camoriano M, Seshadri M, Evans SS, Kane JM 3rd, Skitzki JJ. Water: a simple solution for tumor spillage. Ann Surg Oncol 2011;18:2357-63. [PMID: 21301970 DOI: 10.1245/s10434-011-1588-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
210 Nowacki M, Alyami M, Villeneuve L, Mercier F, Hubner M, Willaert W, Ceelen W, Reymond M, Pezet D, Arvieux C, Khomyakov V, Lay L, Gianni S, Zegarski W, Bakrin N, Glehen O. Multicenter comprehensive methodological and technical analysis of 832 pressurized intraperitoneal aerosol chemotherapy (PIPAC) interventions performed in 349 patients for peritoneal carcinomatosis treatment: An international survey study. Eur J Surg Oncol 2018;44:991-6. [PMID: 29526367 DOI: 10.1016/j.ejso.2018.02.014] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 12.3] [Reference Citation Analysis]
211 Tan F, Liu F, Liu H, Hu Y, Liu D, Li G. CTHRC1 is associated with peritoneal carcinomatosis in colorectal cancer: a new predictor for prognosis. Med Oncol 2013;30:473. [PMID: 23359115 DOI: 10.1007/s12032-013-0473-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
212 Bhandare M, Patil P, Pai V, Bhamre R, Engineer R, Ostwal V, Saklani A. Peritoneal Carcinomatosis in Colorectal Cancers - Management Perspective Needs a Change. Clin Colorectal Cancer 2017;16:e1-6. [PMID: 27670895 DOI: 10.1016/j.clcc.2016.08.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
213 Dinh L, Hong J, Min Kim D, Lee G, Jung Park E, Hyuk Baik S, Hwang SJ. A novel thermosensitive poloxamer-hyaluronic acid- kappa-carrageenan-based hydrogel anti-adhesive agent loaded with 5-fluorouracil: a preclinical study in Sprague-Dawley rats. Int J Pharm 2022;:121771. [PMID: 35487401 DOI: 10.1016/j.ijpharm.2022.121771] [Reference Citation Analysis]
214 Evers DJ, Smeenk RM, Bottenberg PD, van Werkhoven ED, Boot H, Verwaal VJ. Effect of preservation of the right gastro-epiploic artery on delayed gastric emptying after cytoreductive surgery and HIPEC: a randomized clinical trial. Eur J Surg Oncol. 2011;37:162-167. [PMID: 21216560 DOI: 10.1016/j.ejso.2010.12.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
215 de la Fuente A, Alonso-Alconada L, Costa C, Cueva J, Garcia-Caballero T, Lopez-Lopez R, Abal M. M-Trap: Exosome-Based Capture of Tumor Cells as a New Technology in Peritoneal Metastasis. J Natl Cancer Inst 2015;107:djv184. [PMID: 26150590 DOI: 10.1093/jnci/djv184] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 7.0] [Reference Citation Analysis]
216 Lefevre JH, Elias DM. Cytoreductive surgery plus intraperitoneal chemohyperthermia in patients with colorectal cancer at high risk for local-regional recurrence. Cancer J 2009;15:200-3. [PMID: 19556905 DOI: 10.1097/PPO.0b013e3181a58f1d] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
217 Hahismoto S, Yazawa S, Asao T, Faried A, Nishimura T, Tsuboi K, Nakagawa T, Yamauchi T, Koyama N, Umehara K, Saniabadi AR, Kuwano H. Novel sugar-cholestanols as anticancer agents against peritoneal dissemination of tumor cells. Glycoconj J 2008;25:531-44. [PMID: 18327639 DOI: 10.1007/s10719-008-9108-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
218 Akgül Ö, Çetinkaya E, Ersöz Ş, Tez M. Role of surgery in colorectal cancer liver metastases. World J Gastroenterol. 2014;20:6113-6122. [PMID: 24876733 DOI: 10.3748/wjg.v20.i20.6113.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
219 Chua TC, Pelz JO, Morris DL. Surgery for colorectal peritoneal carcinomatosis. Scand J Gastroenterol 2012;47:277-85. [PMID: 22263634 DOI: 10.3109/00365521.2012.640825] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
220 Chua TC, Liauw W, Morris DL. The St George Hospital Peritoneal Surface Malignancy Program--where are we now? ANZ J Surg. 2009;79:416-418. [PMID: 19566860 DOI: 10.1111/j.1445-2197.2009.04940.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
221 Coccolini F, Gheza F, Lotti M, Virzì S, Iusco D, Ghermandi C, Melotti R, Baiocchi G, Giulini SM, Ansaloni L, Catena F. Peritoneal carcinomatosis. World J Gastroenterol 2013; 19(41): 6979-6994 [PMID: 24222942 DOI: 10.3748/wjg.v19.i41.6979] [Cited by in CrossRef: 135] [Cited by in F6Publishing: 116] [Article Influence: 15.0] [Reference Citation Analysis]
222 Dresen RC, De Vuysere S, De Keyzer F, Van Cutsem E, Prenen H, Vanslembrouck R, De Hertogh G, Wolthuis A, D'Hoore A, Vandecaveye V. Whole-body diffusion-weighted MRI for operability assessment in patients with colorectal cancer and peritoneal metastases. Cancer Imaging 2019;19:1. [PMID: 30616608 DOI: 10.1186/s40644-018-0187-z] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 11.0] [Reference Citation Analysis]
223 Tanaka K, Okugawa Y, Toiyama Y, Inoue Y, Saigusa S, Kawamura M, Araki T, Uchida K, Mohri Y, Kusunoki M. Brain-derived neurotrophic factor (BDNF)-induced tropomyosin-related kinase B (Trk B) signaling is a potential therapeutic target for peritoneal carcinomatosis arising from colorectal cancer. PLoS One. 2014;9:e96410. [PMID: 24801982 DOI: 10.1371/journal.pone.0096410] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 5.1] [Reference Citation Analysis]
224 Erroi F, Scarpa M, Angriman I, Cecchetto A, Pasetto L, Mollica E, Bettiol M, Ruffolo C, Polese L, Cillo U. Ovarian metastasis from colorectal cancer: prognostic value of radical oophorectomy. J Surg Oncol. 2007;96:113-117. [PMID: 17443728 DOI: 10.1002/jso.20803] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 3.1] [Reference Citation Analysis]
225 Framery B, Gutowski M, Dumas K, Evrard A, Muller N, Dubois V, Quinonero J, Scherninski F, Pèlegrin A, Cailler F. Toxicity and pharmacokinetic profile of SGM-101, a fluorescent anti-CEA chimeric antibody for fluorescence imaging of tumors in patients. Toxicol Rep 2019;6:409-15. [PMID: 31080749 DOI: 10.1016/j.toxrep.2019.04.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
226 Gelli M, Huguenin JF, Cerebelli C, Benhaim L, Honoré C, Elias D, Goéré D. Strategies to prevent peritoneal carcinomatosis arising from colorectal cancer. Future Oncol 2017;13:907-18. [PMID: 28052691 DOI: 10.2217/fon-2016-0389] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
227 Sánchez-Velázquez P, Moosmann N, Töpel I, Piso P. “En bloc” caudate lobe and inferior vena cava resection following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal and liver metastasis of colorectal cancer. World J Gastroenterol 2016; 22(46): 10249-10253 [PMID: 28028374 DOI: 10.3748/wjg.v22.i46.10249] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
228 De Vlieghere E, Gremonprez F, Verset L, Mariën L, Jones CJ, De Craene B, Berx G, Descamps B, Vanhove C, Remon JP, Ceelen W, Demetter P, Bracke M, De Geest BG, De Wever O. Tumor-environment biomimetics delay peritoneal metastasis formation by deceiving and redirecting disseminated cancer cells. Biomaterials 2015;54:148-57. [PMID: 25907048 DOI: 10.1016/j.biomaterials.2015.03.012] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
229 van Dam GM, Themelis G, Crane LM, Harlaar NJ, Pleijhuis RG, Kelder W, Sarantopoulos A, de Jong JS, Arts HJ, van der Zee AG, Bart J, Low PS, Ntziachristos V. Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results. Nat Med 2011;17:1315-9. [PMID: 21926976 DOI: 10.1038/nm.2472] [Cited by in Crossref: 1046] [Cited by in F6Publishing: 946] [Article Influence: 95.1] [Reference Citation Analysis]
230 Sugarbaker PH. Improving oncologic outcomes for colorectal cancer at high risk for local-regional recurrence with novel surgical techniques. Expert Rev Gastroenterol Hepatol 2016;10:205-13. [PMID: 26643935 DOI: 10.1586/17474124.2016.1110019] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
231 Nindra U, Shahnam A, Mahon KL. Review of systemic chemotherapy in unresectable colorectal peritoneal carcinomatosis. Asia Pac J Clin Oncol 2021. [PMID: 33609014 DOI: 10.1111/ajco.13552] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
232 Elias D, Lefevre JH, Chevalier J, Brouquet A, Marchal F, Classe J, Ferron G, Guilloit J, Meeus P, Goéré D, Bonastre J. Complete Cytoreductive Surgery Plus Intraperitoneal Chemohyperthermia With Oxaliplatin for Peritoneal Carcinomatosis of Colorectal Origin. JCO 2009;27:681-5. [DOI: 10.1200/jco.2008.19.7160] [Cited by in Crossref: 571] [Cited by in F6Publishing: 211] [Article Influence: 43.9] [Reference Citation Analysis]
233 Harlaar NJ, Koller M, de Jongh SJ, van Leeuwen BL, Hemmer PH, Kruijff S, van Ginkel RJ, Been LB, de Jong JS, Kats-Ugurlu G, Linssen MD, Jorritsma-Smit A, van Oosten M, Nagengast WB, Ntziachristos V, van Dam GM. Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: a single-centre feasibility study. Lancet Gastroenterol Hepatol. 2016;1:283-290. [PMID: 28404198 DOI: 10.1016/s2468-1253(16)30082-6] [Cited by in Crossref: 82] [Cited by in F6Publishing: 57] [Article Influence: 13.7] [Reference Citation Analysis]
234 Verheij FS, Bakkers C, van Eden WJ, Aalbers AGJ, Nienhuijs SW, Jóźwiak K, de Hingh IHJT, Kok NFM. Comparison of the Peritoneal Cancer Index and Dutch region count as tools to stage patients with peritoneal metastases of colorectal cancer. BJS Open 2020. [PMID: 32573969 DOI: 10.1002/bjs5.50313] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
235 Hentzen JEKR, Rovers KP, Kuipers H, van der Plas WY, Been LB, Hoogwater FJH, van Ginkel RJ, Hemmer PHJ, van Dam GM, de Hingh IHJT, Kruijff S. Impact of Synchronous Versus Metachronous Onset of Colorectal Peritoneal Metastases on Survival Outcomes After Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicenter, Retrospective, Observational Study. Ann Surg Oncol 2019;26:2210-21. [PMID: 30877495 DOI: 10.1245/s10434-019-07294-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
236 Rynne-Vidal A, Jiménez-Heffernan JA, Fernández-Chacón C, López-Cabrera M, Sandoval P. The Mesothelial Origin of Carcinoma Associated-Fibroblasts in Peritoneal Metastasis. Cancers (Basel) 2015;7:1994-2011. [PMID: 26426054 DOI: 10.3390/cancers7040872] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 5.0] [Reference Citation Analysis]
237 Vatandoust S, Price TJ, Karapetis CS. Colorectal cancer: Metastases to a single organ. World J Gastroenterol 2015; 21(41): 11767-11776 [PMID: 26557001 DOI: 10.3748/wjg.v21.i41.11767] [Cited by in CrossRef: 112] [Cited by in F6Publishing: 100] [Article Influence: 16.0] [Reference Citation Analysis]
238 Segelman J, Granath F, Holm T, Machado M, Mahteme H, Martling A. Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer. Br J Surg. 2012;99:699-705. [PMID: 22287157 DOI: 10.1002/bjs.8679] [Cited by in Crossref: 224] [Cited by in F6Publishing: 201] [Article Influence: 22.4] [Reference Citation Analysis]
239 Reingruber B, Boettcher M, Klein P, Hohenberger W, Pelz J. Hyperthermic intraperitoneal chemoperfusion is an option for treatment of peritoneal carcinomatosis in children. Journal of Pediatric Surgery 2007;42:e17-21. [DOI: 10.1016/j.jpedsurg.2007.06.009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
240 Dineen SP, Robinson KA, Roland CL, Beaty KA, Rafeeq S, Mansfield PF, Royal RE, Fournier KF. Feeding tube placement during cytoreductive surgery and heated intraperitoneal chemotherapy does not improve postoperative nutrition and is associated with longer length of stay and higher readmission rates. Journal of Surgical Research 2016;200:158-63. [DOI: 10.1016/j.jss.2015.08.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
241 Downs-Canner S, Shuai Y, Ramalingam L, Pingpank JF, Holtzman MP, Zeh HJ, Bartlett DL, Choudry HA. Safety and efficacy of combined resection of colorectal peritoneal and liver metastases. J Surg Res 2017;219:194-201. [PMID: 29078882 DOI: 10.1016/j.jss.2017.05.126] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
242 Ganesalingam R, Lubowski DZ. Collaborate or treat intra-abdominal metastatic colon cancer of the liver and peritoneum: which is practical for the colorectal surgeon? ANZ J Surg 2017;87:648-9. [PMID: 28876546 DOI: 10.1111/ans.14111] [Reference Citation Analysis]
243 Piso P, Stierstorfer K, Gerken M, Klinkhammer-schalke M. Benefit of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with isolated peritoneal metastases from colorectal cancer. Int J Colorectal Dis 2018;33:1559-67. [DOI: 10.1007/s00384-018-3146-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
244 Al-Haidari AA, Algethami N, Lepsenyi M, Rahman M, Syk I, Thorlacius H. Neutrophil extracellular traps promote peritoneal metastasis of colon cancer cells. Oncotarget 2019;10:1238-49. [PMID: 30815227 DOI: 10.18632/oncotarget.26664] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
245 Dahdaleh FS, Sherman SK, Witmer HD, Dhiman A, Rajeev R, Poli EC, Johnston FM, Turaga KK. Potential evidence of peritoneal recurrence in Stage-II colon cancer from the control arm of CALGB9581. The American Journal of Surgery 2022. [DOI: 10.1016/j.amjsurg.2022.01.017] [Reference Citation Analysis]
246 Lepsenyi M, Algethami N, Al-Haidari AA, Algaber A, Syk I, Rahman M, Thorlacius H. CXCL2-CXCR2 axis mediates αV integrin-dependent peritoneal metastasis of colon cancer cells. Clin Exp Metastasis 2021;38:401-10. [PMID: 34115261 DOI: 10.1007/s10585-021-10103-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
247 Trumbeckaite S, Cesna V, Jasukaitiene A, Baniene R, Gulbinas A. Different mitochondrial response to cisplatin and hyperthermia treatment in human AGS, Caco-2 and T3M4 cancer cell lines. J Bioenerg Biomembr 2018;50:329-38. [DOI: 10.1007/s10863-018-9764-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
248 Adachi T, Hinoi T, Egi H, Shimomura M, Ohdan H. Oxaliplatin and molecular-targeted drug therapies improved the overall survival in colorectal cancer patients with synchronous peritoneal carcinomatosis undergoing incomplete cytoreductive surgery. Surg Today. 2015;45:986-992. [PMID: 25156007 DOI: 10.1007/s00595-014-1017-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
249 Lemoine L, Sugarbaker P, Van der Speeten K. Pathophysiology of colorectal peritoneal carcinomatosis: Role of the peritoneum. World J Gastroenterol 2016; 22(34): 7692-7707 [PMID: 27678351 DOI: 10.3748/wjg.v22.i34.7692] [Cited by in CrossRef: 59] [Cited by in F6Publishing: 41] [Article Influence: 9.8] [Reference Citation Analysis]
250 Yoon DH, Ibrahim A, Tatishchev S, Duldulao MPN, Lee SW, Shin J. Prevalence of mesothelin expression in peritoneal disease from colorectal and appendiceal cancers. J Surg Oncol 2021. [PMID: 34310720 DOI: 10.1002/jso.26610] [Reference Citation Analysis]
251 Rijpkema M, Oyen WJ, Bos D, Franssen GM, Goldenberg DM, Boerman OC. SPECT- and Fluorescence Image–Guided Surgery Using a Dual-Labeled Carcinoembryonic Antigen–Targeting Antibody. J Nucl Med 2014;55:1519-24. [DOI: 10.2967/jnumed.114.142141] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.8] [Reference Citation Analysis]
252 Schaaf L, van der Kuip H, Zopf W, Winter S, Münch M, Mürdter TE, Thon KP, Steurer W, Aulitzky WE, Ulmer C. A Temperature of 40 °C Appears to be a Critical Threshold for Potentiating Cytotoxic Chemotherapy In Vitro and in Peritoneal Carcinomatosis Patients Undergoing HIPEC. Ann Surg Oncol 2015;22 Suppl 3:S758-65. [PMID: 26350370 DOI: 10.1245/s10434-015-4853-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
253 Roh SJ, Park SC, Choi J, Lee JS, Lee DW, Hong CW, Han KS, Park HC, Sohn DK, Oh JH. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy With Mitomycin C Used for Colorectal Peritoneal Carcinomatosis. Ann Coloproctol 2020;36:22-9. [PMID: 32146785 DOI: 10.3393/ac.2019.04.30] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
254 Kajdi ME, Beck-Schimmer B, Held U, Kofmehl R, Lehmann K, Ganter MT. Anaesthesia in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: retrospective analysis of a single centre three-year experience. World J Surg Oncol 2014;12:136. [PMID: 24886171 DOI: 10.1186/1477-7819-12-136] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 5.3] [Reference Citation Analysis]
255 Fujii S, Shimada H, Yamagishi S, Ota M, Kunisaki C, Ike H, Ichikawa Y. Evaluation of intraperitoneal lavage cytology before colorectal cancer resection. Int J Colorectal Dis. 2009;24:907-914. [PMID: 19475411 DOI: 10.1007/s00384-009-0733-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
256 Gremonprez F, Willaert W, Ceelen W. Animal models of colorectal peritoneal metastasis. Pleura Peritoneum 2016;1:23-43. [PMID: 30911606 DOI: 10.1515/pp-2016-0006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
257 Alzahrani N, Ung L, Valle SJ, Liauw W, Morris DL. Synchronous liver resection with cytoreductive surgery for the treatment of liver and peritoneal metastases from colon cancer: results from an Australian centre: Synchronous liver resection with CRS. ANZ Journal of Surgery 2017;87:E167-72. [DOI: 10.1111/ans.13231] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
258 Yan TD, Sim J, Morris DL. Selection of Patients with Colorectal Peritoneal Carcinomatosis for Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy. Ann Surg Oncol 2007;14:1807-17. [DOI: 10.1245/s10434-007-9350-7] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 3.1] [Reference Citation Analysis]
259 Chan CH, Cusack JC, Ryan DP. A critical look at local-regional management of peritoneal metastasis. Hematol Oncol Clin North Am 2015;29:153-8. [PMID: 25475577 DOI: 10.1016/j.hoc.2014.09.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
260 Riss S, Mohamed F, Dayal S, Cecil T, Stift A, Bachleitner-Hofmann T, Moran B. Peritoneal metastases from colorectal cancer: patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol. 2013;39:931-937. [PMID: 23810280 DOI: 10.1016/j.ejso.2013.06.001] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
261 Lemmens VE, Klaver YL, Verwaal VJ, Rutten HJ, Coebergh JW, de Hingh IH. Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study. Int J Cancer. 2011;128:2717-2725. [PMID: 20715167 DOI: 10.1002/ijc.25596] [Cited by in Crossref: 199] [Cited by in F6Publishing: 187] [Article Influence: 16.6] [Reference Citation Analysis]
262 Arjona-Sánchez A, Medina-Fernández FJ, Muñoz-Casares FC, Casado-Adam A, Sánchez-Hidalgo JM, Rufián-Peña S. Peritoneal metastases of colorectal origin treated by cytoreduction and HIPEC: An overview. World J Gastrointest Oncol 2014; 6(10): 407-412 [PMID: 25320657 DOI: 10.4251/wjgo.v6.i10.407] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
263 Simkens GA, Rovers KP, Nienhuijs SW, de Hingh IH. Patient selection for cytoreductive surgery and HIPEC for the treatment of peritoneal metastases from colorectal cancer. Cancer Manag Res 2017;9:259-66. [PMID: 28721098 DOI: 10.2147/CMAR.S119569] [Cited by in Crossref: 28] [Cited by in F6Publishing: 14] [Article Influence: 5.6] [Reference Citation Analysis]
264 Helderman RFCPA, Löke DR, Kok HP, Oei AL, Tanis PJ, Franken NAPK, Crezee J. Variation in Clinical Application of Hyperthermic Intraperitoneal Chemotherapy: A Review. Cancers (Basel) 2019;11:E78. [PMID: 30641919 DOI: 10.3390/cancers11010078] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 10.7] [Reference Citation Analysis]
265 Bezan A, Hohla F, Meissnitzer T, Greil R. Systemic effect of catumaxomab in a patient with metastasized colorectal cancer: a case report. BMC Cancer 2013;13:618. [PMID: 24380380 DOI: 10.1186/1471-2407-13-618] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
266 Kulu Y, Dorfman JD, Kuruppu D, Fuchs BC, Goodwin JM, Fujii T, Kuroda T, Lanuti M, Tanabe KK. Comparison of intravenous versus intraperitoneal administration of oncolytic herpes simplex virus 1 for peritoneal carcinomatosis in mice. Cancer Gene Ther 2009;16:291-7. [PMID: 18989355 DOI: 10.1038/cgt.2008.83] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
267 Ubink I, Bolhaqueiro ACF, Elias SG, Raats DAE, Constantinides A, Peters NA, Wassenaar ECE, de Hingh IHJT, Rovers KP, van Grevenstein WMU, Laclé MM, Kops GJPL, Borel Rinkes IHM, Kranenburg O. Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy. Br J Surg 2019;106:1404-14. [PMID: 31197820 DOI: 10.1002/bjs.11206] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 9.0] [Reference Citation Analysis]
268 Chua TC, Liauw W, Koong H, Esquivel J. Surgical Therapies in Metastatic Colorectal Cancer With a Potential for Cure. American Journal of Clinical Oncology 2011;34:326-31. [DOI: 10.1097/coc.0b013e3181dbb9ad] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
269 Bouquet W, Ceelen W, Adriaens E, Almeida A, Quinten T, De Vos F, Pattyn P, Peeters M, Remon JP, Vervaet C. In vivo toxicity and bioavailability of Taxol and a paclitaxel/beta-cyclodextrin formulation in a rat model during HIPEC. Ann Surg Oncol. 2010;17:2510-2517. [PMID: 20339948 DOI: 10.1245/s10434-010-1028-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
270 Piso P, Slowik P, Popp F, Dahlke MH, Glockzin G, Schlitt HJ. Safety of gastric resections during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis. Ann Surg Oncol. 2009;16:2188-2194. [PMID: 19408049 DOI: 10.1245/s10434-009-0478-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
271 Rumpold H, Kirchweger P, Niedersüß-Beke D, Falch D, Wundsam H, Metz-Gercek S, Piringer G, Thaler J. Prognostic value of metastatic pattern in colorectal cancer: a multicenter retrospective analysis in a real-life cohort. Acta Oncol 2021;60:180-6. [PMID: 33095652 DOI: 10.1080/0284186X.2020.1837945] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
272 Keese M, Yagublu V, Schwenke K, Post S, Bastiaens P. Fluorescence lifetime imaging microscopy of chemotherapy-induced apoptosis resistance in a syngenic mouse tumor model. Int J Cancer 2010;126:104-13. [PMID: 19588498 DOI: 10.1002/ijc.24730] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
273 Thirunavukarasu P, Sathaiah M, Gorry MC, O'Malley ME, Ravindranathan R, Austin F, Thorne SH, Guo ZS, Bartlett DL. A rationally designed A34R mutant oncolytic poxvirus: improved efficacy in peritoneal carcinomatosis. Mol Ther 2013;21:1024-33. [PMID: 23439499 DOI: 10.1038/mt.2013.27] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
274 Carpizo DR, D'Angelica M. Liver resection for metastatic colorectal cancer in the presence of extrahepatic disease. Lancet Oncol. 2009;10:801-809. [PMID: 19647200 DOI: 10.1016/s1470-2045(09)70081-6] [Cited by in Crossref: 70] [Cited by in F6Publishing: 19] [Article Influence: 5.4] [Reference Citation Analysis]
275 van Gestel YR, Thomassen I, Lemmens VE, Pruijt JF, van Herk-Sukel MP, Rutten HJ, Creemers GJ, de Hingh IH. Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer. Eur J Surg Oncol. 2014;40:963-969. [PMID: 24183168 DOI: 10.1016/j.ejso.2013.10.001] [Cited by in Crossref: 80] [Cited by in F6Publishing: 76] [Article Influence: 8.9] [Reference Citation Analysis]
276 Jeune F, Brouquet A, Caramella C, Gayet M, Abdalla S, Verin AL, Thirot Bidault A, Penna C, Benoist S. Cardiophrenic angle lymph node is an indicator of metastatic spread but not specifically peritoneal carcinomatosis in colorectal cancer patients: Results of a prospective validation study in 91 patients. Eur J Surg Oncol. 2016;42:861-868. [PMID: 27010101 DOI: 10.1016/j.ejso.2016.02.256] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
277 Park SY, Choi GS, Park JS, Kim HJ, Ryuk JP, Yun SH, Kim JG, Kang BW. Laparoscopic cytoreductive surgery and early postoperative intraperitoneal chemotherapy for patients with colorectal cancer peritoneal carcinomatosis: initial results from a single center. Surg Endosc. 2014;28:1555-1562. [PMID: 24368743 DOI: 10.1007/s00464-013-3351-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
278 Koppe MJ, Nagtegaal ID, de Wilt JH, Ceelen WP. Recent insights into the pathophysiology of omental metastases. J Surg Oncol. 2014;110:670-675. [PMID: 24962271 DOI: 10.1002/jso.23681] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
279 Yan TD. Peritoneal carcinomatosis of colorectal origin: standard of care. Ann Surg. 2006;244:632-63; author reply 632-63;. [PMID: 16998376 DOI: 10.1097/01.sla.0000239629.96036.cd] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
280 Prasanna T, Karapetis CS, Roder D, Tie J, Padbury R, Price T, Wong R, Shapiro J, Nott L, Lee M, Chua YJ, Craft P, Piantadosi C, Sorich M, Gibbs P, Yip D. The survival outcome of patients with metastatic colorectal cancer based on the site of metastases and the impact of molecular markers and site of primary cancer on metastatic pattern. Acta Oncol. 2018;57:1438-1444. [PMID: 30035653 DOI: 10.1080/0284186x.2018.1487581] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 7.8] [Reference Citation Analysis]
281 Franiel T, Diederichs G, Engelken F, Elgeti T, Rost J, Rogalla P. Multi-detector CT in peritoneal carcinomatosis: diagnostic role of thin slices and multiplanar reconstructions. Abdom Imaging. 2009;34:49-54. [PMID: 18264738 DOI: 10.1007/s00261-008-9372-z] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
282 Sabino FD, Campos CF, Caetano CE, Trotte MN, Oliveira AV, Marques RG. Effects of TachoSil and 5-fluorouracil on colonic anastomotic healing. J Surg Res. 2014;192:375-382. [PMID: 24976442 DOI: 10.1016/j.jss.2014.05.067] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
283 Kim MH, Yoo YC, Bai SJ, Lee KY, Kim N, Lee KY. Physiologic and hemodynamic changes in patients undergoing open abdominal cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. J Int Med Res 2021;49:300060520983263. [PMID: 33445991 DOI: 10.1177/0300060520983263] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
284 Cottone L, Capobianco A, Gualteroni C, Monno A, Raccagni I, Valtorta S, Canu T, Di Tomaso T, Lombardo A, Esposito A, Moresco RM, Maschio AD, Naldini L, Rovere-Querini P, Bianchi ME, Manfredi AA. Leukocytes recruited by tumor-derived HMGB1 sustain peritoneal carcinomatosis. Oncoimmunology 2016;5:e1122860. [PMID: 27467932 DOI: 10.1080/2162402X.2015.1122860] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
285 Ziauddin MF, Guo ZS, O'Malley ME, Austin F, Popovic PJ, Kavanagh MA, Li J, Sathaiah M, Thirunavukarasu P, Fang B, Lee YJ, Bartlett DL. TRAIL gene-armed oncolytic poxvirus and oxaliplatin can work synergistically against colorectal cancer. Gene Ther 2010;17:550-9. [PMID: 20182517 DOI: 10.1038/gt.2010.5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
286 Barat M, Soyer P, Eveno C, Dautry R, Perronne L, Guerrache Y, Boudiaf M, Pocard M, Dohan A. The presence of cardiophrenic angle lymph nodes is not an indicator of peritoneal carcinomatosis from colorectal cancer on MDCT: Results of a case-control study. European Journal of Surgical Oncology (EJSO) 2016;42:266-72. [DOI: 10.1016/j.ejso.2015.11.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
287 Goldberg EM, Berger Y, Sood D, Kurnit KC, Kim JS, Lee NK, Yamada SD, Turaga KK, Eng OS. Differences in Sociodemographic Disparities Between Patients Undergoing Surgery for Advanced Colorectal or Ovarian Cancer. Ann Surg Oncol 2021. [PMID: 33959831 DOI: 10.1245/s10434-021-10086-y] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
288 Ihemelandu C, Naeem A, Parasido E, Berry D, Chaldekas K, Harris BT, Rodriguez O, Albanese C. Clinicopathologic and prognostic significance of LGR5, a cancer stem cell marker in patients with colorectal cancer. Colorectal Cancer 2019;8:CRC11. [PMID: 32038737 DOI: 10.2217/crc-2019-0009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
289 Sugarbaker PH, Ryan DP. Cytoreductive surgery plus hyperthermic perioperative chemotherapy to treat peritoneal metastases from colorectal cancer: standard of care or an experimental approach? Lancet Oncol. 2012;13:e362-e369. [PMID: 22846841 DOI: 10.1016/s1470-2045(12)70210-3] [Cited by in Crossref: 98] [Cited by in F6Publishing: 42] [Article Influence: 9.8] [Reference Citation Analysis]
290 Franko J, Gusani NJ, Holtzman MP, Ahrendt SA, Jones HL, Zeh HJ, Bartlett DL. Multivisceral resection does not affect morbidity and survival after cytoreductive surgery and chemoperfusion for carcinomatosis from colorectal cancer. Ann Surg Oncol. 2008;15:3065-3072. [PMID: 18712450 DOI: 10.1245/s10434-008-0105-x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 3.4] [Reference Citation Analysis]
291 Shan L, Bai B, Lv Y, Xie B, Huang X, Zhu H. Lobaplatin suppresses proliferation and peritoneal metastasis of colorectal cancer in a preclinical model. Biomed Pharmacother 2018;108:486-91. [PMID: 30243080 DOI: 10.1016/j.biopha.2018.09.063] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
292 Tremblay JF, Sideris L, Leblond FA, Trépanier JS, Badrudin D, Drolet P, Mitchell A, Dubé P. Electrocautery effect on intestinal vascularisation in a murine model. Int J Hyperthermia 2016;32:643-7. [PMID: 27270101 DOI: 10.1080/02656736.2016.1181276] [Reference Citation Analysis]
293 Lemstrova R, Flasarova D, Spisarova M, Melichar B, Lovecek M, Havlik R, Neoral C, Mohelnikova-Duchonova B, Klos D. Evaluation and management of toxicity of cytoreductive surgery/hyperthermic intraperitoneal chemotherapy: the initial experience of a single centre study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2020;164:300-6. [PMID: 31435073 DOI: 10.5507/bp.2019.035] [Reference Citation Analysis]
294 van Eden WJ, Kok NFM, Woensdregt K, Huitema ADR, Boot H, Aalbers AGJ. Safety of intraperitoneal Mitomycin C versus intraperitoneal oxaliplatin in patients with peritoneal carcinomatosis of colorectal cancer undergoing cytoreductive surgery and HIPEC. Eur J Surg Oncol 2018;44:220-7. [PMID: 29258720 DOI: 10.1016/j.ejso.2017.10.216] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
295 Piaton E, Villeneuve L, Maurice C, Paulin C, Cottier M, Fontanière B, Salle M, Seigneurin D, Vancina S, Decullier E. Intraperitoneal free cancer cells in non-gynaecological adenocarcinomas: a reproducibility study. Cytopathology. 2012;23:242-249. [PMID: 21736645 DOI: 10.1111/j.1365-2303.2011.00889.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
296 Shimizu T, Murata S, Sonoda H, Mekata E, Ohta H, Takebayashi K, Miyake T, Tani T. Hyperthermic intraperitoneal chemotherapy with mitomycin C and 5-fluorouracil in patients at high risk of peritoneal metastasis from colorectal cancer: A preliminary clinical study. Mol Clin Oncol 2014;2:399-404. [PMID: 24772307 DOI: 10.3892/mco.2014.244] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
297 Barriuso J, Nagaraju RT, Belgamwar S, Chakrabarty B, Burghel GJ, Schlecht H, Foster L, Kilgour E, Wallace AJ, Braun M, Dive C, Evans DG, Bristow RG, Saunders MP, O'Dwyer ST, Aziz O. Early Adaptation of Colorectal Cancer Cells to the Peritoneal Cavity Is Associated with Activation of "Stemness" Programs and Local Inflammation. Clin Cancer Res 2021;27:1119-30. [PMID: 33257424 DOI: 10.1158/1078-0432.CCR-20-3320] [Reference Citation Analysis]
298 Navez J, Remue C, Leonard D, Bachmann R, Kartheuser A, Hubert C, Coubeau L, Komuta M, Van den Eynde M, Zech F, Jabbour N. Surgical Treatment of Colorectal Cancer with Peritoneal and Liver Metastases Using Combined Liver and Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Report from a Single-Centre Experience. Ann Surg Oncol 2016;23:666-73. [PMID: 27646023 DOI: 10.1245/s10434-016-5543-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
299 Kamiyama H, Noda H, Konishi F, Rikiyama T. Molecular biomarkers for the detection of metastatic colorectal cancer cells. World J Gastroenterol 2014; 20(27): 8928-8938 [PMID: 25083065 DOI: 10.3748/wjg.v20.i27.8928] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
300 Kyang LS, Valle SJ, Alzahrani NA, Morris DL. Prevention of peritoneal recurrence in high-risk colorectal cancer and evidence of T4 status as a potential risk factor: Prevention of high-risk CRPM. ANZ Journal of Surgery 2018;88:975-81. [DOI: 10.1111/ans.14428] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
301 Mulsow J, Merkel S, Agaimy A, Hohenberger W. Outcomes following surgery for colorectal cancer with synchronous peritoneal metastases. Br J Surg. 2011;98:1785-1791. [PMID: 22034185 DOI: 10.1002/bjs.7653] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
302 Ge W, Chen G, Fan XS. Pathway of peritoneal carcinomatosis maybe hematogenous metastasis rather than peritoneal seeding. Oncotarget 2017;8:41549-54. [PMID: 28099909 DOI: 10.18632/oncotarget.14607] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
303 Gao H, Meng XY, Wang HQ, Zhu FF, Guo AL, Zhu M, Song JC, Yu WF. Association between Anaesthetic Technique and Oncological Outcomes after Colorectal Carcinoma Liver Metastasis Resection. Int J Med Sci 2019;16:337-42. [PMID: 30745816 DOI: 10.7150/ijms.28016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
304 Linke R, Klein A, Seimetz D. Catumaxomab: clinical development and future directions. MAbs. 2010;2:129-136. [PMID: 20190561 DOI: 10.4161/mabs.2.2.11221] [Cited by in Crossref: 146] [Cited by in F6Publishing: 134] [Article Influence: 13.3] [Reference Citation Analysis]
305 Raspé C, Flöther L, Schneider R, Bucher M, Piso P. Best practice for perioperative management of patients with cytoreductive surgery and HIPEC. Eur J Surg Oncol 2017;43:1013-27. [PMID: 27727026 DOI: 10.1016/j.ejso.2016.09.008] [Cited by in Crossref: 53] [Cited by in F6Publishing: 40] [Article Influence: 8.8] [Reference Citation Analysis]
306 Lam JY, Mcconnell YJ, Rivard JD, Temple WJ, Mack LA. Hyperthermic intraperitoneal chemotherapy + early postoperative intraperitoneal chemotherapy versus hyperthermic intraperitoneal chemotherapy alone: assessment of survival outcomes for colorectal and high-grade appendiceal peritoneal carcinomatosis. The American Journal of Surgery 2015;210:424-30. [DOI: 10.1016/j.amjsurg.2015.03.008] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
307 Sluiter NR, Vlek SL, Wijsmuller AR, Brandsma HT, de Vet HCW, van Grieken NCT, Kazemier G, Tuynman JB. Narrow-Band Imaging Improves Detection of Colorectal Peritoneal Metastases: A Clinical Study Comparing Advanced Imaging Techniques.Ann Surg Oncol. 2019;26:156-164. [PMID: 30421052 DOI: 10.1245/s10434-018-7005-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
308 Matsuda K, Hotta T, Takifuji K, Kobayashi Y, Tsuji T, Nagai Y, Horiuchi T, Yamaue H. Lymph Nodes Ratio Is Associated with the Survival of Colorectal Cancer Patients with Peritoneal Carcinomatosis. The American Surgeon 2011;77:602-7. [DOI: 10.1177/000313481107700521] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
309 Song SE, Choi P, Kim JH, Jung K, Kim SE, Moon W, Park MI, Park SJ. Diagnostic Value of Carcinoembryonic Antigen in Ascites for Colorectal Cancer with Peritoneal Carcinomatosis. Korean J Gastroenterol 2018;71:332-7. [PMID: 29943560 DOI: 10.4166/kjg.2018.71.6.332] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
310 Feingold PL, Klemen ND, Kwong MLM, Hashimoto B, Rudloff U. Adjuvant intraperitoneal chemotherapy for the treatment of colorectal cancer at risk for peritoneal carcinomatosis: a systematic review. Int J Hyperthermia 2018;34:501-11. [PMID: 29214884 DOI: 10.1080/02656736.2017.1401742] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
311 van Oudheusden TR, Braam HJ, Nienhuijs SW, Wiezer MJ, van Ramshorst B, Luyer MD, Lemmens VE, de Hingh IH. Cytoreduction and hyperthermic intraperitoneal chemotherapy: a feasible and effective option for colorectal cancer patients after emergency surgery in the presence of peritoneal carcinomatosis. Ann Surg Oncol 2014;21:2621-6. [PMID: 24671638 DOI: 10.1245/s10434-014-3655-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
312 Yonemura Y, Iahibashi H, Sako S, Mizumoto A, Takao N, Ichinose M, Motoi S, Liu Y, Wakama S, Kamada Y, Nishihara K. Advances with pharmacotherapy for peritoneal metastasis. Expert Opin Pharmacother 2020;21:2057-66. [PMID: 32783786 DOI: 10.1080/14656566.2020.1793957] [Reference Citation Analysis]
313 Lopes CV, Pesenti C, Bories E, Caillol F, Giovannini M. Self-expandable metallic stents for palliative treatment of digestive cancer. J Clin Gastroenterol. 2008;42:991-996. [PMID: 18719511 DOI: 10.1097/MCG.0b013e31815b0d81] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
314 Akgül &, Çetinkaya E, Ersöz Ş, Tez M. Role of surgery in colorectal cancer liver metastases. World J Gastroenterol 2014; 20(20): 6113-6122 [PMID: 24876733 DOI: 10.3748/wjg.v20.i20.6113] [Cited by in CrossRef: 86] [Cited by in F6Publishing: 82] [Article Influence: 10.8] [Reference Citation Analysis]
315 Franko J, Shi Q, Goldman CD, Pockaj BA, Nelson GD, Goldberg RM, Pitot HC, Grothey A, Alberts SR, Sargent DJ. Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841. J Clin Oncol. 2012;30:263-267. [PMID: 22162570 DOI: 10.1200/jco.2011.37.1039] [Cited by in Crossref: 333] [Cited by in F6Publishing: 132] [Article Influence: 30.3] [Reference Citation Analysis]
316 Bae SJ, Shin US, Ki YJ, Cho SS, Moon SM, Park SH. Role of peritoneal lavage cytology and prediction of prognosis and peritoneal recurrence after curative surgery for colorectal cancer. Ann Coloproctol. 2014;30:266-273. [PMID: 25580413 DOI: 10.3393/ac.2014.30.6.266] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
317 Narasimhan V, Warrier S, Michael M, McCormick J, Ramsay R, Lynch C, Heriot A. Perceptions in the management of colorectal peritoneal metastases: A bi-national survey of colorectal surgeons. Pleura Peritoneum 2019;4:20190022. [PMID: 31799373 DOI: 10.1515/pp-2019-0022] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
318 Alavi S, Haeri A, Mahlooji I, Dadashzadeh S. Tuning the Physicochemical Characteristics of Particle-Based Carriers for Intraperitoneal Local Chemotherapy. Pharm Res 2020;37. [DOI: 10.1007/s11095-020-02818-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
319 Stein MK, Williard FW, Xiu J, Tsao MW, Martin MG, Deschner BW, Dickson PV, Glazer ES, Yakoub D, Shibata D, Grothey AF, Philip PA, Hwang JJ, Shields AF, Marshall JL, Korn WM, Lenz HJ, Deneve JL. Comprehensive tumor profiling reveals unique molecular differences between peritoneal metastases and primary colorectal adenocarcinoma. J Surg Oncol 2020;121:1320-8. [PMID: 32166754 DOI: 10.1002/jso.25899] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
320 Ceelen WP, Bracke ME. Peritoneal minimal residual disease in colorectal cancer: mechanisms, prevention, and treatment. Lancet Oncol. 2009;10:72-79. [PMID: 19111247 DOI: 10.1016/s1470-2045(08)70335-8] [Cited by in Crossref: 84] [Cited by in F6Publishing: 32] [Article Influence: 6.5] [Reference Citation Analysis]
321 Boonstra MC, van Driel PB, van Willigen DM, Stammes MA, Prevoo HA, Tummers QR, Mazar AP, Beekman FJ, Kuppen PJ, van de Velde CJ, Löwik CW, Frangioni JV, van Leeuwen FW, Sier CF, Vahrmeijer AL. uPAR-targeted multimodal tracer for pre- and intraoperative imaging in cancer surgery. Oncotarget 2015;6:14260-73. [PMID: 25895028 DOI: 10.18632/oncotarget.3680] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 5.7] [Reference Citation Analysis]
322 Baratti D, Kusamura S, Pietrantonio F, Guaglio M, Niger M, Deraco M. Progress in treatments for colorectal cancer peritoneal metastases during the years 2010-2015. A systematic review. Crit Rev Oncol Hematol 2016;100:209-22. [PMID: 26867984 DOI: 10.1016/j.critrevonc.2016.01.017] [Cited by in Crossref: 62] [Cited by in F6Publishing: 51] [Article Influence: 10.3] [Reference Citation Analysis]
323 Suh DH, Kim K, Kim JW. Major clinical research advances in gynecologic cancer in 2011. J Gynecol Oncol 2012;23:53-64. [PMID: 22355468 DOI: 10.3802/jgo.2012.23.1.53] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
324 Hompes D, Tiek J, Wolthuis A, Fieuws S, Penninckx F, Van Cutsem E, D'Hoore A. HIPEC in T4a colon cancer: a defendable treatment to improve oncologic outcome? Ann Oncol 2012;23:3123-9. [PMID: 22831982 DOI: 10.1093/annonc/mds173] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 4.2] [Reference Citation Analysis]
325 Zani S, Papalezova K, Stinnett S, Tyler D, Hsu D, Blazer DG. Modest advances in survival for patients with colorectal-associated peritoneal carcinomatosis in the era of modern chemotherapy: Advances in CRC-Associated PC Survival. J Surg Oncol 2013;107:307-11. [DOI: 10.1002/jso.23222] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
326 Piso P, Glockzin G, von Breitenbuch P, Sulaiman T, Popp F, Dahlke M, Esquivel J, Schlitt HJ. Patient Selection for a Curative Approach to Carcinomatosis. The Cancer Journal 2009;15:236-42. [DOI: 10.1097/ppo.0b013e3181a58f30] [Cited by in Crossref: 25] [Cited by in F6Publishing: 6] [Article Influence: 1.9] [Reference Citation Analysis]
327 Roohullah A, Wong HL, Sjoquist KM, Gibbs P, Field K, Tran B, Shapiro J, Mckendrick J, Yip D, Nott L, Gebski V, Ng W, Chua W, Price T, Tebbutt N, Chantrill L. Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumab. World J Gastroenterol 2015; 21(17): 5352-5358 [PMID: 25954110 DOI: 10.3748/wjg.v21.i17.5352] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
328 Takemoto K, Shiozaki A, Ichikawa D, Komatsu S, Konishi H, Nako Y, Murayama Y, Kuriu Y, Nakanishi M, Fujiwara H, Okamoto K, Sakakura C, Nakahari T, Marunaka Y, Otuji E. Evaluation of the efficacy of peritoneal lavage with distilled water in colorectal cancer surgery: in vitro and in vivo study. J Gastroenterol 2015;50:287-97. [PMID: 24908098 DOI: 10.1007/s00535-014-0971-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
329 Lee JH, Ahn BK, Baik SS, Lee KH. Comprehensive Analysis of Somatic Mutations in Colorectal Cancer With Peritoneal Metastasis. In Vivo 2019;33:447-52. [PMID: 30804124 DOI: 10.21873/invivo.11493] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
330 Leung V, Huang N, Liauw W, Morris DL. High risk features of primary colorectal carcinomas which subsequently undergo peritonectomy. Eur J Surg Oncol 2016;42:836-40. [PMID: 26995114 DOI: 10.1016/j.ejso.2015.08.161] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]